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Phylogenetic Analysis and Molecular Characterization of Human 
Immunodeficiency Virus in Serbia 
Introduction 
Human immunodeficiency virus (HIV) is a retrovirus, the causative agent of 
Acquired immunodeficiency syndrome (AIDS). Since the beginning of the 
epidemic over 35 years ago, more than 78 million people have been infected so 
far and over 30 million have died. The high genetic variability and rapid 
evolution of HIV have been critical to its persistence and spread throughout the 
world. HIV-1 and HIV-2 comprise two distinct types of HIV. HIV-1 has 
diversified extensively into numerous genetic forms, including four groups (M, 
N, O, P), of which group M is causing the pandemic of HIV infection and AIDS. 
Group M viruses are further classified in multiple phylogenetically distinct 
subtypes (A-D, F, G, H, J and K), sub-subtypes (A1, A2, F1 and F2) and 
numerous recombinant forms. The global distribution of HIV-1 is complex and 
dynamic with regional epidemics representing only a subset of the global 
diversity. Molecular phylogenetic analysis, a method of reconstructing 
evolutionary relationships between nucleotide sequences, is one of the 
strategies for studying viral diversity and transmission dynamics. It is 
estimated that around half of HIV infected people are undiagnosed, making 
identification of transmission networks important for targeted public health 
intervention programs. In this doctoral dissertation modern phylogenetic 
techniques were used to identify HIV-1 sequences from Serbia, to characterize 
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the molecular epidemiology and transmission dynamics which is crucial to 
understand the actual characteristics of the Serbian HIV-1 epidemic. 
The Aims of the Study    
The aims of this research were to determine the current prevalence and 
distribution of HIV-1 subtypes in Serbia. The objectives also included 
identification of local transmission networks and reconstruction of the history 
of the introduction of founder strains. Different molecular footprints on HIV-1 
sequences and their association with duration of infection and phylogenetic 
clustering were also investigated. 
Materials and Methods 
The study enrolled HIV-1 seropositive patients attending the HIV/AIDS 
Center, University Hospital for Infectious and Tropical Diseases, Clinical Centre 
of Sebia, Belgrade. Blood samples from 155 patients were collected from 2008 to 
2013, whereas 162 HIV-1 sequences from Serbian isolates deposited in the NCBI 
database, dating from 1997 to 2007, were also included in the study. Nested-
PCR (Polymerase chain reaction) method was used for amplification of the pol 
and env gene of HIV-1. All positive PCR products were directly sequenced and 
further analyzed by different phylogenetic and other bioinformatics approach. 
HIV-1 subtypes and circulating recombinant forms (CRF) were identified both 
by REGA subtyping tool and phylogenetic analysis of the pol gene sequences. 
Overall, 304 sequences were analysed with different phylogenetic software 
packages, depending on specific objective. Phylogenetic trees reconstruction 
was performed using different methods including Bayesian inference of 
phylogeny as well as dedicated softwares such as MEGA, PAUP and MrBayes. 
All analyses were performed under nucleotide substitution model that was 
chosen based on the likelihood scores obtained by jModeltest. In order to 
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identify transmission clusters, defined as viral lineages derived from the same 
variant in the Serbian population, we applied different series of rigorous criteria 
sets, based on genetic distance and bootstrap support. A different approach, 
based on Bayesian phylogenetic inference, has been employed here to elucidate 
the ancestry of HIV-1 clades. A bioinformatics approach was used to estimate 
the duration of infection by calculating the fraction of ambiguous nucleotides in 
the sequence as a delimiter for more recent (less than 1 year) versus chronic 
infection (longer than 1 year). By analyzing complete dataset of subtype B 
sequences, prevalence of amino acid (aa) substitutions at 245 codon, and 
association with duration of infection and phylogenetic clustering, were 
investigated. 
Results 
Results of this study showed that among HIV-1 infected patients in Serbia 
subtype B predominated 90.8% (129/142), while the prevalence of non B 
subtypes was 9.2% (13/142). Phylogenetic analyses, that included 304 viral 
sequences, revealed a number of transmission clusters that accomplished all 
predefined criteria sets, along with one large transmission network. All 
sequences within transmission clusters and transmission network were 
identified as subtype B sequences. In total, 42.2% (116/275) of viral pol gene 
sequences were found within local phylogenetic clusters, while 57.8% (159/275) 
were found intermixed in the phylogenetic tree with sequences sampled Europe 
and America, indicative of multiple subtype B introductions. The majority of 
clustering sequences 82.7% (96/116) were from male patients living in Belgrade 
that predominantly reported MSM (men who have sex with men) as 
transmission category. The tMRCA (time of the Most Recent Common 
Ancestor) inferred for the local subtype B transmission network composed of 45 
sequences was in 1994 (95% Higher Posterior Density (HPD): 1982–2000). 
Estimated temporal origin for the largest local subtype B, MSM associated 
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transmission cluster composed of 13 sequences was much more recent, 2004 
(95% HPD: 2002–2006). The early nineties were found to be temporal origin of 
subtype G in Serbia, 1991 (95% HPD: 1979–2000). Results of the phylogenetic 
exploration of one particular transmission cluster in a forensic context have 
shown query samples to form a well-supported transmission chain, in support 
of the a priori hypothesis of their epidemiological linkage. However, in spite of 
the cluster topology with paraphyly of subject 1 sequences to those of subjects 2 
and 3, this finding is not sufficient to unambiguously prove the transmission 
event and its direction. Based on the threshold of 0.47% ambiguous bases per 
sequence a total of 55.1% of samples (114/207) were classified as a recent 
infection, of duration of less than 1 year, whereas among subtype B samples this 
percentage was 54% (58/180). The predominant aa at RT codon 245 was the 
wild type valine (V), found in 61% (168/275), hence 36.7% (101/275) contained 
mutation at this position. The most common substitution at RT codon 245 was 
methionine (M) 22.9% (63/275), followed by glutamic acid (E) 7.2% (20/275), 
glutamine (Q) 5.4% (15/275) and others. Very high prevalence 93.6% (41/45) of 
aa substitutions at the investigated position was found among sequences from 
transmission network. 
Conclusions 
Results obtained in this research, enable drawing a more comprehensive and 
dynamic picture of the HIV-1 epidemic Serbia. HIV epidemics in Serbia 
continues to be dominated with subtype B, but with changes in distribution of 
non B subtypes over time, the emergence of new non B subtypes and increased 
genetic diversity among them. In this study we characterized a chain of 
ongoing subtype B HIV-1 transmission spanning the period of 16 years. Results 
of this research showed that the most encountered risk factor for infection with 
subtype B virus was the MSM transmission. Furthermore, transmission clusters 
were highly associated with MSM rather than other transmission risks. Our 
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data support the need for increased public health interventions targeting MSM. 
This research indicated that local epidemic spread within transmission 
networks and outside the firstly implicated IDUs community dating from the 
beginning of the nineties, while epidemic spread of HIV subtype B among 
MSMs represents the most recent HIV-1 epidemic in Serbia. Based on 
transmission clusters analyses forensic application of phylogenetics was also 
explored. Estimation of the duration of infection, based on the ambiguous 
nucleotides sequence content, suggested an increasing proportion of recent 
infections, significantly higher in the second half of the study period. Equal 
prevalence of RT 245 substitutions in samples from recent and chronic HIV 
infection, together with high prevalence of this polymorphism in sequences 
within transmission network, might suggest early fixation of an HLA induced 
selective imprint, during intra-host viral evolution. Significantly higher 
prevalence of RT 245 substitution, compared to the preliminary reports of the 
HLA-B*57-01 allele frequency in HIV infected population in Serbia, was found. 
Keywords: HIV, HIV-1 Serbian epidemic, subtypes, genetic diversity, 
phylogenetic analyses, transmission clusters, molecular footprints, 
bioinformatic analyses 
Scientific field: Molecular Medicine / Virology 
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Filogenetska analiza i molekularna karakterizacija virusa humane 
imunodeficijencije u Srbiji 
Uvod 
Virus humane imunodeficijencije (HIV) je retrovirus koji uzrokuje sindrom 
stečene imunodeficijencije.  Od početka epidemije pre 35 godina, ovim virusom 
je inficirano više od 78 miliona ljudi a preko 30 miliona je umrlo. Visoka 
genetička varijabilnost i brza evolucija HIV-a su ključni uzroci opstanka i 
globalnog širenjaepidemije. HIV je filogenetski klasifikovan u dva tipa: HIV-1 i 
HIV-2. Visoki diverzitet HIV-1 ogleda u postojanju četiri grupe (M, N, O, P) od 
kojih su virusi grupe M uzročnici globalne HIV-1 pandemije. Grupa M virusa je 
podeljena u više filogenetski različitih podtipova (A-D, F-H, J i K), pod-
podtipove (A1, A2, F1 i F2) i cirkulišuće rekombinantne forme. Distribucija 
podtipova u svetu je složena i dinamična sa regionalnim HIV-1 epidemijama 
unutar globalnog diverziteta. Molekularna filogenetska analiza, metod za 
rekonstrukciju evolutivnih odnosa između nukleotidnih sekvenci, je tehnika za 
proučavanje varijabilnosti virusa i dinamike transmisije unutar regionalnih 
populacija. Procenjuje se da kod blizu polovine inficiranih osoba HIV infekcija 
nije dijagnostikovana, zbog čega je identifikacija puteva transmisije izuzetno 
značajna u cilju javno zdravstvenog nadzora. U ovom istraživanju primenjene 
su savremene filogenetske metode u analizi HIV-1 sekvenci izolata iz Srbije u 
cilju karakterizacije molekularne epidemiologije i dinamike transmisije, što je 
ključno za bolje razumevanje karakteristika aktuelne HIV-1 epidemije u Srbiji. 
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Ciljevi 
Ciljevi ovog istraživanja bili su određivanje aktuelne distribucije podtipova 
HIV-1 u Srbiji. Ciljevi su obuhvatili i analizu transmisionih lanaca kao i 
filogenetsko datiranje epidemije za najzastupljenije HIV-1 podtipove u Srbiji. 
Istraživanje je takođe obuhvatilo analizu učestalosti i svojstava izmena 
nukleotidne sekvence genoma koje su odraz trajanja HIV-1 infekcije i interakcije 
virusa i domaćina. 
Materijal i metode 
U istraživanje su uključeni HIV-1 seropozitivni pacijenti praćeni u odeljenju za 
HIV/AIDS, Klinike za infektivne i tropske bolesti, Kliničkog centra Srbije, u 
Beogradu. Uzorci krvi od 155 pacijenata uključenih u studiju uzimani su u 
periodu od 2008. do 2013. godine, a dodatno su u istraživanje uključene 162 
sekvence sojeva iz Srbije deponovane u NCBI bazi podataka, koje su generisane 
u periodu od 1997. do 2007. godine. Sekvence pol i env gena umnožene su 
metodom reakcije lančane polimerizacije u dva kruga (engl. „nested 
polymerase chain reaction“-nested PCR). DNK sekvence svih pozitivnih PCR 
produkata su analizirane filogenetskim i drugim bioinformatičkim metodama. 
Identifikacija podtipova i cirkulišućih rekombinantnih formi izvršena je 
pomoću REGA alata za genotipizaciju kao i filogenetskom analizom pol 
sekvenci. Ukupno, 304 virusne sekvence analizirane su različitim filogenetskim 
softverskim paketima, u zavisnosti od postavljenog cilja. Konstrukcija 
filogenetskih stabala je urađena primenom različitih filogenetskih metoda, 
uključujući metode Bajesove statistike, korišćenjem kompjuterskih programa 
MEGA, Paup i MrBayes. Filogenetska analiza urađena je na osnovu 
nukleotidnog substitucionog modela izabranog na osnovu skora verovatnoće 
pomoću Jmodeltest programa. U cilju identifikacije transmisionih lanaca, 
definisanih kao skup virusnih varijanti koje potiču od istog soja, primenjeni su 
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višestruki strogo definisani kriterijumi zasnovani na nukleotidnoj distanci i 
statističkoj podršci filogenetskom grupisanju. Primenjene su različite analize 
koje se zasnivaju na Bajesovoj statistici u cilju filogenetskog datiranja epidemije 
za najzastupljenije HIV-1 podtipove u Srbiji. Bioinformatički pristup, zasnovan 
na analizi učestalosti pojave istovremеnog prisustva različitih baza na istoj 
poziciji u genomu, poslužio je kao molekularni marker u proceni rane (kraće od 
godinu dana) ili hronične (duže od godinu dana) HIV-1 infekcije. Posebno je 
analiziran nukleotidni sastav i izmena kodona na poziciji 245 RT produkta pol 
gena HIV-1 kao i povezanost promena sa dužinom trajanja infekcije i 
filogenetskim grupisanjem.  
Rezultati 
Rezultati ovog istraživanja su pokazali da je među HIV-1 inficiranim osobama u 
Srbiji dominantan podtip B virusa, sa prevalencijom od 90,8% (129/142), dok je 
prevalencija drugih podtipova iznosila 9,2% (13/142). Filogenetskom analizom, 
u koju su uključene 304 virusne sekvence, identifikovano je prisustvo većeg 
broja transmisionih klastera i jedna transmisiona mreža. Sve sekvence u okviru 
transmisionih klastera i transmisione mreže identifikovane su kao podtip B. 
Ukupno, 42,2% (116/275) virusnih sekvenci pol gena podtipa B pokazalo je 
lokalno filogenetsko grupisanje, dok je 57,8% (159/275) sekvenci filogenetski 
pomešano sa izolatima iz Evrope i Amerike, što ukazuje na višestruko poreklo 
HIV-1 epidemije u Srbiji. Većina sekvenci unutar filogenetski grupisanih 
sekvenci 82,7% (96/116), poticala je od pacijenata iz Beograda, muškog pola, 
kojima je najverovatniji način izlaganja HIV infekciji bio seksualni kontakt 
(muškarci koji imaju seksualne odnose sa muškarcima – MSM). Analizom je 
procenjeno da najraniji zajednički predak transmisione mreže, sačinjene od 45 
virusnih sekvenci, potiče iz 1994. godine (95% IP : 1982–2000.). Procenjeno 
poreklo najvećeg transmission klastera sačinjenog od 11 virusnih sekvenci, 
dominanto izolovanih iz pacijenata koji su prijavili homoseksualni odnos kao 
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rizik infekcije, je znatno kasnije 2004. godina (95% IP: 2002–2006.).  Analiza 
porekla podtip G sekvenci izolata iz Srbije pokazala je da je naraniji predak 
poreklom iz 1991 (95% IP: 1979–2000.). Filogenetsko istraživanje jednog 
transmisionog klastera u kontekstu forenzičke analize pokazalo je da ispitivani 
uzorci formiraju jasno izdvojen transmisioni lanac, u prilog a priori hipotezi o 
njihovoj epidemiološkoj povezanosti. Međutim, uprkos utvrđenoj topologiji 
filogenetskog stabla i parafiliji sekvenci subjekta 1 u odnosu na subjekte 2 i 3, 
dobijeni rezultati ne mogu sa sigurnošću da dokažu neposrednu transmisiju 
virusa između dva subjekta, kao ni smer transmisije. Analiza učestalosti pojave 
istovremnog prisustva različitih baza na istoj poziciji u genomu, na osnovu 
usvojene granice od 0,47% za ukupno 54% ispitanih virusnih sekvenci podtipa 
B ukazivala je na trajanje infekcije kraće od godinu dana. Na poziciji 245 
produkta RT gena u najvećem procentu 61% (168/275) identifikovana je 
aminokiselina divljeg soja virusa, aminokiselina valin (V), dok je 36.7% 
(101/275) na toj poziciji imalo aminokiselinsku izmenu. Najzastpljenija 
promena aminokiselina na poziciji 245 produkta RT gena bila je metionin (М) 
22.9% (63/275), zatim glutaminska kiselina (E) 7.7% (20/275), glutamin (Q) 
5.5% (15/275), i ostale. Veoma visoka prevalenca, 93.6% (41/45), promene 
aminokiseline na ispitivanoj poziciji pronađena je u okviru sekvenci koje su 
obuhvađene transmisionom mrežom, dok je jednaka prevalence ove substitucije 
pronađena među sekvencama rane i hronične infekcije. 
Zaključak 
Dobijeni rezultati doprinose stvaranju detaljne i jasne slike kompleksne HIV-1 
epidemije u Srbiji. HIV-1 epidemijom u Srbiji i dalje dominira podtip B virusa, 
ali sa promenom distribucije drugih podtipova kroz godine, pojavom novih 
podtipova i povećanjem diverziteta među njima. U ovom istraživanju 
okarakterisani su lanci transmisije podtip B virusa u Srbiji, dominantno 
povezani sa seksulanom transmisijom MSM kontaktom. Pokazano je da je 
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širenje HIV-1 epidemije unutar lokalnih transmisionih mreža počelo početkom 
devedesetih godina, dok je širenje među pacijentima mlađeg uzasta, iz 
Beograda, sa MSM kontaktom kao rizikom za transmisiju virusa počelo znatno 
kasnije i predstavlja najskoriju epidemiju. Na slučaju jednog transmisionog 
klastera ispitana je forenzička primena filogenetske analize. Analiza dužine 
trajanja infekcije, pokazala je statističi značajno veću zastupljenost rane infekcije 
u periodu od 2008. do 2013. godine. Ista prevalenca substitucije na kodonu 245 
među sekvencama rane i hronične infekcije, uz visoku prevalencu iste 
substitucije u okviru sekvenci transmisione mreže, ukazuje na ranu fiksaciju 
ove promene nastale HLA selektivnim pritiskom. Pronađena je značajno viša 
prevalenca substitucije na kodonu 245 u odnosu na preliminarne rezultate 
frekvence alela HLA B* 57-01 među HIV-1 inficiranim pacijentima iz Srbije. 
Ključne reči: HIV, HIV-1 epidemija u Srbiji, podtipovi, genetički diverzitet, 
filogenetska analiza, transmisioni klasteri, molekularni markeri, 
bioinformatička analiza 
Naučna disciplina: Molekularna medicina / Virusologija 
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 Chapter  1.  Introduction 
1.1    OVERVIEW OF HIV INFECTION AND AIDS PANDEMIC8kk88kkk88 
1.1.1  DISCOVERY OF HIVJJJJJJJJJJJJJččJJJJJJJJlllll 
Symptoms of Acquired Immunodeficiency Syndrome (AIDS) were first 
described in 1981 as unusually high occurrence of pneumonia caused by 
Pneumocystis carinii (now renamed as P. jirovecii) as reported by Centers for 
Disease Control and Prevention (CDC) in Atlanta, Georgia, USA. At the 
beginning, all disease cases were diagnosed among previously healthy men 
who had sex with men (MSM), living in New York and Los Angeles, USA 
(Galo, 2006; Gottlieb et al., 1981, Masur et al., 1981). Soon after, aggressive forms 
of Kaposi sarcoma, an otherwise rarely seen opportunistic tumor caused by 
Human Herpesvirus 8 (HHV-8), was diagnosed in eight young men in New 
York (Friedman-Kien et al., 1981; Hymes et al., 1981). Both of these conditions 
were known to occur only in severely immunocompromised patients, and none 
of the initial cases had any known cause of immunodeficiency. Soon after these 
first reports, a number of further similar cases with similar symptoms were 
discovered leading to conclusion that it was a new undefined disease associated 
with the breakdown of the immune system. This unusual clinical finding of 
Kaposi's sarcoma in a population much exposed to sexually transmissible 
diseases suggests that such exposure may play a role in its pathogenesis 
(Hyemes et al., 1981). Initially referred to as gay related immune deficiency 
(GRID), the clustering in homosexual men with the promiscuous life stile and 
the history  of numerous sexually transmitted infections, the clustering in 
homosexual men and the association with high numbers of sexual partners and 
previous sexually transmitted infections, alerted epidemiologists to the 
possibility of a sexually transmitted agent being responsible (Greene, 2007). 
However, soon after, the disease was recognized in other population groups as
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well. This included females closely associated with intravenous drug abuse 
either by shared tools or sexual contact with an drug abuser (Masur et al., 1982), 
their offsprings (Oleske et al., 1983), hemophiliacs (Bloom, 1984) and blood 
transfusion recipients (Peterman et al., 1984). 
In 1983, scientists around Luc Montagnier and Françoise Barré-Sinoussi 
and their research group of at the Institute Pasteur in Paris, were the first who 
isolated the causative virus of AIDS, a discovery for which they were awarded 
with the Nobel Prize for Physiology or Medicine twenty-five years later (Barré-
Sinoussi et al., 1983). The first isolated HIV, in 1983, was the prototype of what 
was later designated as HIV type 1 (HIV-1) group M (HIV-M) and is the virus 
responsible for the current pandemic. Barre-Sinoussi and co-workers recovered 
a retrovirus from the lymph node of an individual suffering from 
lymphadenopathy syndrome (LAS), an AIDS associated condition. AIDS was 
initially described as the appearance of very rare, dramatic and life-threatening 
opportunistic infections and/or opportunistic tumors, due to severe depletion 
of the immune system (Ammamm et al., 1983). The scientists at the Pasteur 
Institute in France reported the discovery of a new retrovirus called 
Lymphadenopathy-Associated Virus (LAV) that could be the cause of AIDS 
(Barré-Sinoussi et al., 1983; Ratner et al., 1985a; Ratner et al., 1985b). Almost at 
the same time, the National Cancer Institute announced that they had found the 
cause of AIDS, the retrovirus HTLV-III. In a joint conference with the Pasteur 
Institute they announced that LAV and HTLV-III are identical and the likely 
cause of AIDS. (Marx, 1984). Two years later, the International Committee on 
the Taxonomy of Viruses annouced that the virus that causes AIDS will 
officially be called Human Immunodeficiency Virus (HIV) instead of HTLV-
III/LAV (Case, 1986).  Within a short period of time the spread of the HIV and 
AIDS has reached a pandemic form.  
  4 
 
 Chapter  1.  Introduction 
1.1.2 CURRENT PANDEMIC OF HIV INFECTION AND 
kkkkkkkkkkkkkkMMMMMMMMMMKKKKKKKKKKKKK AIDS
At the time of HIV discovery, it was hard to imagine the proportions that 
the AIDS epidemic would grow to. Over the past 35 years, HIV/AIDS has 
evolved into a highly heterogeneous epidemic structured in multiple sub-
epidemics, each of which are influenced by biological, behavioral, and cultural 
factors (Tebit and Arts, 2011; Beyrer et al., 2012; Brenner and Wainberg, 2013). 
The pandemic of AIDS has become one of the most important global health 
threats due to its mortality and morbidity. The incidence of HIV-1 infections 
reveals the need for multisectorial efforts to combat and reduce the number of 
new infections, increase access to healthcare services, and guarantee access to 
antiretroviral therapy for the general population (UNAIDS, 2015; UNAIDS, 
2013).  It is estimated that 36.7 million people were living with HIV in 2015 and 
more than half of them were in Sub-Saharan Africa, mostly infected through 
unprotected sexual intercourse (Table 1.) (http://www.unaids.org/). In 2015 
there were 2.1 million [1.8 million–2.4 million] new HIV infections worldwide, 
and more than 90 thousand new infections in Western and Central Europe only 
(http://www.who.int/gho/hiv/en/).  
However, since the beginning of the epidemic enormous gains have been 
made and even more can be achieved in the coming years. Development 
of highly active antiretroviral therapy (HAART) has made HIV infection a 
treatable chronic disease. Early HAART is associated with a reduced latent viral 
reservoir, reduced viral DNA, and normalisation of some immune marker. In 
just the last two years the number of people living with HIV on antiretroviral 
therapy has increased by about a third, while since 2010 this number increased 
more than two times, reaching 17  million (Table 2.).   
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No single prevention is effective enough on its own, and many 
interventions are necessary to control the global HIV epidemic. Prevention of 
sexual HIV transmission has been a priority since the beginning of the 
epidemic. However, concerns have shifted from access and availability of HIV 
treatment programs to issues of late presentations, quality of care, HIV drug 
resistance and HIV treatment failure (Apisarnthanarak et al., 2008; Weidle et al., 
2002; Kitkungvan et al., 2008). In particular, treatment failure is a huge problem 
as it leads to transmission of HIV resistant virus, increase in treatment 
complexity and cost, worsening morbidity and mortality and ultimately, failure 
of the HIV treatment program (Gilks et al., 2006; Rajasekaran et al., 2007; 
Robbins et al., 2007). 
New insights into the mechanisms of viral latency and the significance of 
reservoirs of infection might eventually lead to a cure. The importance of 
immune activation in the pathogenesis of non-AIDS clinical events (major 
causes of morbidity and mortality in people on antiretroviral therapy) is 
receiving increased recognition. Breakthroughs in the prevention of HIV 
important to public health include male medical circumcision, antiretrovirals to 
prevent mother-to-child transmission, antiretroviral therapy in people with HIV 
to prevent transmission, and antiretrovirals for pre-exposure prophylaxis. 
Research into other prevention interventions, notably vaccines and vaginal 
microbicides, is in progress. 
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Table 1. Latest estimates of HIV epidemic, globally and by region, 2010 and 
2015. Data from: GARPR 2016; UNAIDS 2016 estimates 
 
 
  People living with HIV (all ages) New HIV infection (all ages) 
  2010 2015 2010 2015 
Global 
33.3 million 36.7 million 2.2 million 2.1 million 
[30.9–36.1 ] [34.0 –39.8 ] [2.0–2.5 ] [1.8 –2.4 ] 
Asia and 
Pacific 
4.7 million 5.1 million 310 000 300 000 
[4.1 –5.5 ] [4.4 –5.9 ] [270 000–360 000] [240 000–380 000] 
Easter and 
Southern 
Africa 
17.2 million 19.0 million 1.1 million 960 000 
[16.1 –18.5 ] [17.7 –20.5 ]  [1.0 –1.2 ] [830 000–1.1 ] 
Eastern 
Europe 
1.0 million 1.5 million 120 000 190 000 
and central 
Asia 
[950 000–1.1] [1.4 –1.7 ] [110 000–130 000] [170 000–200 000] 
Latin America 
and the 
Caribbean 
1.8 million 2.0 million 100 000 100 000 
[1.5 –2.1 ] [1.7 –2.3 ] 86 000–120 000] [86 000–120 000] 
Middle East 
and North 
Africa 
190 000 230 000 20 000 21 000 
[150 000–240 000] 
[160 000–330 
000] 
[15 000–29 000] [12 000–37 000] 
Western and 
central Africa 
6.3 million 6.5 million 450 000 410 000 
[5.2 –7.7 ] [5.3 –7.8 ] [350 000–560 000] [310 000–530 000] 
Western and 
central 
Europe and 
2.1 million 
[1.9 –2.3 ] 
2.4 million 
[2.2 –2.7 ] 
 
 
    92 000 
[89 000–97 000] 
91 000 
[89 000–97 000] 
North 
America 
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Table 2. Latest estimates of number of HIV infected people on HAART and 
AIDS related deaths, globally and by region, 2010 and 2015. 
Data from: GARPR 2016; UNAIDS 2016 estimates 
 
  
People living with HIV on 
antiretroviral treatment (all ages) 
AIDS-related deaths (all ages) 
  2010 2015 2010 2015 
Global 7 501 100 17 025 900 
1.5 million [1.3 
million–1.7 
million] 
1.1 million 
[940 000–1.3 
million] 
Asia and Pacific 907 600  2 071 900  
240 000 
[200 000–270 
000] 
180 000 
[150 000–220 
000] 
Easter and Southern 
Africa 
4 087 500 10 252 400  
760 000 
[670 000–860 
000] 
470 000 
[390 000–560 
000] 
Eastern Europe 
and central Asia 
112 100  321 800  
38 000 
[33 000–45 000] 
47 000 
[39 000–55 
000] 
Latin America and 
the Caribbean 
568 400  1 091 900  
60 000 
[51 000–70 000] 
50 000 
[41 000–59 
000] 
Middle East and 
North Africa 
13 600  38 200  
9500 
[7400–12 000] 
12 000 
[8700–16 000] 
Western and central 
Africa 
905 700  1 830 700  
370 000 
[290 000–470 
000] 
330 000 
[250 000–430 
000] 
Western and central 
Europe and 
North America 
906 200 1 418 900 
29 000 
[27 000–31 000] 
22 000 
[20 000–24 
000] 
 
  
  8 
 
 Chapter  1.  Introduction 
In the world’s most affected region, eastern and southern Africa, the 
number of people on treatment has more than doubled since 2010. AIDS related 
deaths in this region have decreased by 36% since 2010. At the same time the 
number of AIDS deaths is also declining: there were 1.1 (1.4–1.9) million AIDS 
deaths in 2015 while there were 2.3 (2.1–2.6) million in 2005 and 1.6 million in 
2010 (Table 2). However, the prevalence of HIV varies considerably between 
different regions over the world. Sub- Saharan Africa is still the most seriously 
affected region by the HIV pandemic, where the epidemic has become a 
growing human and economic catastrophe (Figure 1). In some of these 
countries (e.g. South Africa, Botswana and Swaziland), almost  every fifth adult 
is infected with HIV. In contrast, most countries in Western and Central Europe 
have prevalence rates of about 0.1% (UNAIDS, 2015). Complex and varied 
social, structural and economic dynamics within countries account for the 
uneven geographical distribution of HIV. Furthermore, important difference 
between regions that account for imbalances lies in the different primary modes 
of transmission (Figure 1). Unlike the sub-Saharan Africa epidemic, in which 
adolescent girls and young women accounted for 25% of new HIV infections, 
while women accounted for 56% of new HIV infections among adults, the 
epidemic affecting western hemisfera is concentrated in high risk groups 
including people who inject drugs (PWID), men who have sex with men (MSM) 
and commercial sex workers, along with a clear trend towards increased 
transmission among  MSM  while the rates of new infections in other high-risk 
groups decreased in the last years (de Oliveira et al., 2017). Consequently Africa 
has also experienced large numbers of infections acquired vertically and in 2007 
2.2 million children were estimated to be living with HIV in sub Saharan Africa. 
Vice versa, in North America and in Western and Central Europe men 
outnumber women in both HIV prevalence and incidence by more than 2:1.  
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. 
Figure 1. Distribution of new HIV infections among population groups, by 
region, 2015. Data from UNAIDS special analysis, 2016. 
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JJJLLLLLLLLLLLLLJJJJJJJJJJJJJJJJJJJl 1.1.3  HIV EPIDEMIC IN SERBIA
In Serbia, the duration of HIV epidemic is similar to the one in Western 
European countries, with first cases registered in 1985. It was initially 
recognized among people who inject drugs (PWID) and this transmission route 
was the most prevalent over the coming years. By the end of the nineties, 
intravenous drug use was still the most prevalent risk among cumulative 
number of HIV/AIDS cases, around 48.9%, followed by sexual transmission, 
33% (Stanojevic et al., 2002 ).  
According to the latest data released by the Institute for Public Health of 
Serbia “Dr Milan Jovanovic Batut” (the National Institution that has the 
mandate for surveillance and monitoring and evaluation of the national 
response on HIV/AIDS) the cumulative number of HIV-infected people 
reported until the end of 2015 was 3312, of whom 1788 developed AIDS while 
1192 died (http://www.batut.org.rs/index.php?category_id=17). In 2015, 178 
newly diagnosed HIV cases, 45 AIDS cases and 15 AIDS-related deaths were 
reported, as well as 4 non-HIV related deaths among people infected with HIV. 
The decreasing trend of AIDS cases and AIDS-related deaths in the last decade 
is the result of the introduction of HAART which is available for all people 
living with HIV (PLHIV) in need and fully covered by Republican Health 
Insurance Fund since 1997. The majority of HIV cases diagnosed in the period 
2002-2015 were from the capital city Belgrade (913 cases or 54%), and Vojvodina 
region (341 cases or 20%), in both of which greatest HIV testing retes were 
achieved. The majority of HIV infected in the past presented with clinical AIDS 
(above 70%), but that trend has been changing recently. Moreover, in the period 
2002-2015 there is a clear increasing trend of asymptomatic HIV infected 
persons at the time of presentation (117 cases or 66% of all newly diagnosed 
HIV cases in 2015 versus 14% in 2002) along with a decreasing trend of newly 
diagnosed AIDS  cases (20% in 2015 versus 48% in 2002). However, Serbia is 
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still a country with a high prevalence of “late presenters” (CD4 count <350 
cells/µl at baseline).  According to current data, out of all newly diagnosed HIV 
infections in 2015 with reported baseline  CD4 counts 56% were “late 
presenters” while 47%  already had AIDS.  
 1.2. HIV-1 PARTICLE AND GENOME  ORGANISATIONLLLLLLLLLLllL 
HIV is a member of the Retroviridae family, Orthoretrovirinae subfamily 
and Lentivirus genus (Sonigo et al., 1985, 
http://ictvonline.org/virusTaxonomy.asp). Retroviruses transmit their 
genomes as a single stranded linear positive sense RNA. Upon cellular 
infection, the positive sense RNA undergoes a process of reverse transcription 
creating double stranded DNA from which transcription occurs and that is also 
capable of integrating into the host genome. The virus therefore encodes and 
carries within the virion an enzyme called RNA dependent DNA polymerase or 
Reverse transcriptase which will transcribe the RNA genome into a double-
stranded DNA intermediate.  
As a group, lentiviruses have a number of common features. This group 
of viruses can infect non dividing cells (such as macrophages) and they express 
a number of regulatory genes in addition to the basic proteins required for the 
maturation of new infectious virions. Furthermore, this viruses cause slowly 
progressive infection which is a function both of their ability to integrate into 
the host chromosome and of their ability to evade host immunity. 
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1.2.1  THE MORPHOLOGY OF HIV PARTICLELLLLLLLLLLLLLLLLLLLLK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. (a) Electron micrograph of HIV paticle. Modified from 
http://virology-online.com/viruses/HIV.htm (b) Schematic 
representationof a single HIV virion. Modified from  
https://ceufast.com/course/aids-hiv-4hr 
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HIV is spherical, membrane-enveloped, pleomorphic virions, 100-120 µm 
in diameter, which contain two copies of single-stranded, positive-sense RNA 
genome (Figure 2.). The lipid bilayer contains several cellular membrane 
proteins, including major histocompatibility (MHC) antigens derived from the 
host cell (Arthur et al., 1992). Interior to the viral envelope, the virus matrix 
protein (MA) surrounds the capsid (CA).  
The main constituents of the HIV-1 particle are Gag polyprotein 
(described below), which makes around 50% of the entire virion mass and the 
viral membrane lipids, which account for around 30% of virion mass (Carlson et 
al., 2008). Other viral and cellular proteins together contribute an additional 
20%, whereas the genomic RNA and other small RNAs amount to 2.5% of 
virion mass. Gag, Gag-Pro-Pol, Env, the two copies of genomic RNA, the tRNA 
primer, and the lipid envelope are all essential for viral replication, whereas the 
relevance of virion incorporation of other cellular and viral accessory proteins, 
small RNA molecules, and specific lipids is generally less well understood. 
Each viral particle contains two unspliced positive-oriented single-stranded 
ribonucleic acid (RNA) molecules. The RNA genome encodes three structural 
polyproteins (Gag, Pol and Env) and six regulatory or accessory proteins (Tat, 
Rev, Vif, Vpr, Vpu and Nef) flanked by noncoding long terminal repeats (LTR) 
at both 5’ and 3’ end, as described below. 
            1.2.2   ORGANISATION OF HIV-1 GENOMEJJJJJJJJJKK 
Each single stranded RNA has a length of about 9.7kb and is bound to 
the nucleocapsid NC (p7) protein and surrounded by enzymes important for 
viral replication and maturation such as protease (PR), reverse transcriptase 
(RT) and integrase (IN), encoded by the viral pol gene. Accessory proteins (Nef, 
Vif, Vpr) can also be found in the viral ribonucleoprotein core structure. A 
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number of host molecules have also been found in the virus particle, although 
their importance is still unclear.  
 
 
 
 
 
Fifteen viral proteins are coded by nine genes in the HIV genome (Figure 
3; Table 3). 
The gag (group-specific antigen) gene provides the physical 
infrastructure of the virus. The gag gene is the precursor of four viral structural 
proteins: p24 (the viral capsid), p6 and p7 (the nucleocapsid proteins), and p17 
(the viral matrix). The p24 CA protein is the main component of viral core 
containing the viral RNA genomes  
The HIV pol gene encodes the viral enzymes protease (PR), reverse 
transcriptase (RT) and integrase (IN). The first viral enzyme encoded by the pol 
gene is Protease. Pol is always produced as a Gag-Pol fusion protein (protein 
Figure 3. Diagram of the genome organization of HIV-1. Modified from Freed (2004) 
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precursor Pr 160)., even though the pol coding region partially overlaps and is 
in the −1 reading frame with respect to gag (Jacks et al., 1988; Ratner et al., 1985) 
The Pr160 polyprotein is formed by ribosomal frameshifting, the process 
whereby ribosomes change the open reading frame to allow for alternative 
translation of mRNA (Hung et al., 1998). During viral maturation, protease 
cleaves the Gag-Pol polyproteins to produce viral enzymes (Protease, Reverse 
transcriptase, Integrase). Moreover, the activity of protease depends on the 
concentration of Gag-Pol polyproteins and the rate of protease-mediated 
autoprocessing is modulated by the adjacent p6 sequence. RT and PR proteins 
are encoded between the base 2258 in the gag gene and the base 3872 in the pol) 
gene.  
RT is another important enzyme encoded by the pol gene Reverse 
transcriptase heterodimer acting as an RNA-DNA-dependent DNA polymerase 
is required to produce viral dsDNA during reverse transcription. and is found 
in all retroviruses (Rodgers et al., 1995; Huang et al., 1998). The mature form of 
HIV-1 RT is a heterodimer that is composed of two related subunits: the larger, 
p66, is 560 amino acids long; the smaller, p51, contains the first 440 amino acids 
of p66 (Lightfoote et al. 1986). The p66 subunit consists of two domains: 
polymerase and RNase H; in the mature HIV-1 RT heterodimer, p66 contains 
the active sites for the two enzymatic activities of RT. Integrase that is a 
multidomain enzyme catalyzes two major reactions (3’-processing and strand 
transfer reactions) to insert the linear, double-stranded viral DNA into human 
chromosomes. In the mature viral particles, integrase is cleaved from the Gag-
Pol polyprotein by viral Protease.  
The env (envelope) gene codes for glycoprotein gp160 which acts as a 
precursor to the glycoproteins gp 120 and gp 41. On the virion surface, there are 
less than 30 envelope spikes consisting of three molecules of gp120 and gp41 
each, connected by noncovalent interactions. Viral antireceptor, env protein 
gp120, consists of five constant (C1 to C5) and five variable regions (V1 to V5). 
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The variable regions are mostly found within regions encoding disulphide-
constrained loops, exposed to the surface and to the host immune system 
(Leonard et al., 1990). The V3 region plays an important role in determining 
cellular tropism, allowing the virus to either use chemokine receptor type 5 
(CCR5) or chemokine receptor type 4 (CXCR4) as its main co-receptor (Briggs et 
al., 2003). The transmembrane glycoprotein gp 41 is also encoded by the env 
gene. gp 41 contains a glycine-rich region which is essential for the membrane 
fusion activity. 
HIV-1 Tat protein (trans acting activator of transcription), is one of the 
essential proteins, which directly enhances HIV-1 replication through 
interaction with HIV-1 long terminal repeat (LTR) promoter (Jeang et al., 1999). 
Tat is therefore a promising target for developing HIV-1 vaccines and anti-HIV-
1 drugs (Ensoli et al., 2006; Hamy et al., 2000).  However, Tat undergoes 
continuous amino acid substitutions. As a consequence, the virus escapes from 
host immunity indicating that genetic diversity of Tat protein in major HIV-1 
subtypes is required to be continuously monitored. 
The HIV-1 protein Rev facilitates the nuclear export of intron-containing 
viral mRNAs by recognizing a structured RNA site, the Rev-response-element 
(RRE), contained in an intron. After translation, Rev enters the nucleus and 
binds the Rev response element (RRE), a ~350 nucleotide, highly structured 
element embedded in the env gene in unspliced and singly spliced viral RNA 
transcripts. Once in the cytoplasm, the complexes dissociate and unspliced and 
singly-spliced viral RNAs are packaged into nascent virions or translated into 
viral structural proteins and enzymes 
The vif, vpr, vpu, and nef genes encodes for accessory proteins, that are 
not necessary for viral propagation. However, experimental observations 
suggest that their role in vivo is very important in the life cycle of HIV.  
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Table 3. HIV-1 genes and associated proteins 
CATEGORY  
 
NAME 
ASSOCIATED PROTEIN  FUNCTION 
structural 
gag p17, p24, p15, p7  
early stages of viral replication; 
RNA targeting to plasma 
membrane; particle assemby; acts 
as viral cytokines 
env 
gp120 
binding to primary receptor CD4 
and coreceptors (CCR5 and 
CXCR4) 
gp41 
 anchors the gp120/gp41 complex 
in the membrane, catalyze the 
membrane fusion reaction 
enzymatic pol 
protease (PR) Gag/Pol cleavage and maturation 
reverse transcriptase (RT) reverse trancription 
integrase (IN) DNA provirus integration 
regulatory 
tat Tat enhances HIV-1 replication  
rev Rev 
facilitates the nuclear export of 
viral mRNAs by recognizing  
accessory 
vpu Vpu 
CD4 downregulation in the 
Endoplasmic Reticulum 
extracellular release of virus 
particles 
vif Vif helps to counteract APOBEC3G 
vpr Vpr 
nuclear transport of the HIV-1 
pre-integration complex (PIC)  
nef Nef 
establishment of high viral loads 
during infection and enhances 
viral pathogenesis 
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Viral infectivity factor (Vif) is an essential accessory protein for HIV-1, 
which critical role in replication was observed shortly after the discovery of 
HIV-1 (Sheehy et al., 2002). Vif protein helps to counteract Apolipoprotein B 
mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G, A3G), a 
potent host restriction factor that inhibits HIV-1 replication. The APOBEC 
family of proteins act as editing enzymes and cause Cytosine to Uracil editing 
and lead to the accumulation of Guanine to Adenine mutations in the proviral 
sense cDNA strand (Malim, 2009). Vif also interacts with Gag polyprotein to 
modulate the Protease mediated proteolytic processing.  
Viral protein R (Vpr) is an accessory protein which plays multiple 
functions to enhance viral expression in the non-dividing cells (e.g. 
macrophages). The protein is responsible for nuclear transport of the HIV-1 pre-
integration complex (PIC) and plays an important role in the extracellular 
release of virus particles (Romani and Engelbrecht, 2009).  
Viral protein U (Vpu) is a membrane-associated accessory protein with 
two major functions of CD4 downregulation in the Endoplasmic Reticulum. 
Furthermore this protein promotes the extracellular release of virus particles. 
Vpu is not incorporated in HIV particles thus is not found in the mature virus 
particle. Negative regulatory factor (Nef) is responsible for the establishment of 
high viral loads during infection and enhances viral pathogenesis, leading to 
faster disease progression (Kirchhoff et al., 2008). 
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1.3. LIFE CYCLE OF HIV  KKKKKKKKkkkkkkkkkkkkkkkkkkkkkkkkK
HIV can infect T-helper lymphocytes, macrophages and other cells of the 
same lineage, such as microglia in the brain, which express low levels of CD4 
molecule. As with all members of Retroviridae family, the HIV replication cycle 
involves target cell recognition and invasion, reverse transcription, integration 
into the host genome and the construction and release of new virions. The 
primary cellular receptor for HIV entry is the CD4 molecule (Bour et al., 1995; 
Deng et al., 1996; Wu et al., 1996). However, the CD4 molecule is by itself not 
sufficient to allow HIV entry. In 1996, the chemokine receptors CCR5 and 
CXCR4 were found to act as coreceptors that mediated HIV infection of CD4+ 
immune cells (Bour et al., 1995; Deng et al., 1996; Dragic et al., 1996; Wu et al., 
1996) 
 CD4 is a single chain class I membrane glycoprotein of the 
immunoglobulin superfamily and its extracellular domain is composed of 370 
amino acids (aa); the amino acids at positions 40–55 are used by HIV for the 
binding process in the first stage of infection (Altfeld et al., 2003; Bour et al., 
1995; Riminton, 2004; Sever, 1989;). 
 General features of the HIV replication cycle are shown in Figure 4. 
The early phase begins with the recognition of the target cell by the mature 
virion and involves all processes leading to integration of the genomic DNA 
into the chromosome of the host cell. The late phase begins with the regulated 
expression of the integrated proviral genome, and involves all processes up to 
virus budding and maturation. HIV entry involves a stepwise series of 
interactions with receptors that initiate conformational changes in the envelope 
glycoproteins. The virus attaches itself to the target cell by adsorbing its 
glycoproteins (the envelope gp120 protein on the surface of HIV) to two host-
cell receptor proteins: the CD4 molecule receptor and CCR5 or CXCR4 co-
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receptors (also known as CC chemokine receptor 5 and CXC chemokine 
receptor 4. The gp120 envelope protein is composed of inner and outer 
domains, named for their expected orientation in the oligomeric viral spike 
(Kwong et al., 2000; Rizzuto et al., 1998). The third variable region (V3) of the 
HIV-1 gp120 envelope glycoprotein is immunodominant and contains features 
essential for coreceptor binding. V3 typically consists of 35 amino acids (range 
31 to 39) and plays a number of important biological roles (Hartley et al., 2005). 
Not only is it critical for coreceptor binding, but it also determines which 
coreceptor, CXCR4 or CCR5, will be used for entry (Hartley et al., 2005). The 
HIV envelope spike mediates binding to receptors and virus entry. The trimeric 
spike is composed of three gp120 exterior and three gp41 transmembrane 
envelope glycoproteins. CD4 binding to gp120 in the spike induces 
conformational changes that allow binding to a coreceptor, either CCR5 or 
CXCR4, which is required for viral entry. CCR5-using (R5) viruses represent the 
major transmissible HIV-1 strains, whereas CXCR4-using (X4) viruses tend to 
arise late in the course of disease. Binding to such a coreceptor induces further 
conformational change causing gp120 to move aside, exposing the trimeric gp41 
structure. The gp41 protein facilitates the fusion of the viral envelope and the 
host-cell membrane. The hydrophobic core of gp41 embeds itself into the cell 
membrane and by coiling of certain domains, the viral membrane is virtually 
pulled towards the cell membrane. This fusion allows the release of HIV 
nucleocapsid into the target cell (Dev et al., 2016). 
Upon release of HIV nucleocapsid containing HIV-RNA and viral 
enzymes reverse transcriptase (RT), integrase (IN) and protease (PR), into the 
host cell cytoplasmic compartment, RT converts the single-stranded viral RNA 
genome into double-stranded DNA (ds DNA). Immediately after viral entry, a 
series of processes take place to form the reverse transcriptase complex (RTC) in 
viral core (Klasse et al., 2012). 
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The accessory protein Vif appears to be important during one or more of 
these early events, perhaps by facilitating the initial stages of reverse 
transcription. Recent reports suggested that reverse transcription takes place in 
the intact capsid core and is triggered by deoxyribonucleotides in the cytoplasm 
after viral entry (Hu et al., 2012; Lu et al., 2004; Burnett et al., 2007). During 
reverse transcription, the intact capsid core moves toward the nuclear pore on 
microtubules and RTC is turned into the pre-integration complex (PIC) (Hu et 
al., 2012). The dsDNA, together with other cellular and viral proteins, forms the 
PIC which is transported to the nucleus through nuclear pore complex (NPC) 
(Freed, 2001). Nuclear localization of the preintegration complex is directed by 
the accessory protein Vpr, which does not contain a nuclear localization signal 
but appears to function by connecting the preintegration complex to the cellular 
Figure 4. The HIV-1 life cycle. 
Modified from Pomerentz et al., 2003. 
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nuclear import machinery (including importin-a and the nucleoporins 
(Fouchier et al., 1997; Freed et al., 1995). In the nucleus, the integrase being part 
of the PIC, assisted by cellular cofactors, catalyzes the insertion of the dsDNA 
into the host chromosome (Freed, 2001). At this stage, the virus is known as a 
provirus. Integration is an irreversible process that is fundamental for its 
replication and long-term persistence in the host, marking an important point of 
HIV infection (Bisgrove et al., 2005; Ciuffi et., 2011). The provirus can then 
remain latent or be active, generating products for the generation of new 
virions. 
After integration viral genes are transcribed along the host cell’s genes. 
The late phase of the virus life cycle begins with the synthesis of unspliced and 
spliced mRNA transcripts, which are transported out of the nucleus for 
translation. Initially, short spliced RNA species that encode the regulatory 
proteins Tat, Rev and Nef are synthesized. Tat is an essential transcriptional 
activator that binds to a stemloop element of the nascent RNA transcript (TAR, 
for trans-activating response element) and recruits the cellular proteins cyclin T 
and cyclin-dependent protein kinase-9 (Cdk9; previously called TAK).  
Ordinarily, unspliced cellular mRNAs are retained in the nucleus where 
they can be further processed or degraded. However, full length and singly 
spliced HIV mRNA transcripts that contain functional introns are needed in the 
cytoplasm for Gag and Gag-Pol synthesis and packaging, and their export is 
mediated by the essential HIV accessory protein Rev. 
Unspliced, intron containing, viral RNA, assisted by Rev protein, is 
transported from nucleus to cytoplasm where it is packed into the new 
structures (Cochrane et al., 2014; Vercruysse et al., 2013). HIV-1, like all 
retroviruses, selectively incorporates two copies of the capped and 
polyadenylated full-length RNA genome into the virion. The envelope 
polyprotein gp160 is transported to plasma membrane via the endoplasmatic 
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reticulum and the Golgi complex where it is subjected to extensive N-
glycosylation resulting in long mannose chains. It then undergoes trimerization 
and is cleaved by a host protease into its gp120 and gp41 subunits (Freed, 2001). 
Trimeric gp120–gp41 protein complexes are integrated into the host cell’s 
membrane after expression in the ER. Here, it is essential that, assisted by Vpu 
in the ER and by Nef on the cell’s surface, CD4 is degraded, preventing viral 
spikes immediate binding. The precursor proteins Gag and GagPol also 
associate at the plasma membrane of the host cell where the formation of new 
virus particles begins. During budding from the cell the newly constructed 
virions are enveloped by fragments of this spike-enriched cell membrane. Viral 
protease being part of the GagPol precursor protein gets activated when the 
respective domains of two GagPol precursors dimerize. PR then cleaves the Gag 
and Gag-Pol polyproteins into their subunits. After maturation, they are 
capable of infecting other target cells. Replication is estimated to take 1-2 days. 
HIV-1 buds at the plasma membrane of infected cells and the viral membrane is 
therefore derived from the cellular plasma membrane. 
1.4. PHASES OF HIV-1 DISEASE PROGRESSION  KKllllllllllllllllllllllllKK
After the initial cross species transmission from chimpanzee to humans, 
HIV continued to spread through human population via three main 
transmission routes: sexual contact, blood-to-blood contact (mostly intravenous 
drug use), and transmission from mother to child (vertical transmission). The 
probability of HIV transmission depends on the amount of the infectious virus 
particles present in the body fluid, mainly blood and genital fluid in the index 
patient and the extent of exposure (Tabele 4.). 
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HIV disease staging and classification systems are important tools for 
tracking and monitoring the HIV epidemic and for providing clinicians and 
patients with important information about HIV disease stage and clinical 
management. Two major classification systems currently are in use: the U.S. 
Centers for Disease Control and Prevention (CDC) classification system and the 
World Health Organization (WHO) Clinical Staging and Disease Classification 
System. 
The CDC disease staging system (most recently revised in 1998) 
categorizes persons on the basis of clinical conditions associated with HIV 
infection and CD4+ T- lymphocyte count (www.cdc.gov). The system is based 
on three ranges of CD4+ T- lymphocyte counts and three clinical categories and 
is represented by a matrix of nine mutually exclusive categories. It provides 
uniform and simple criteria for categorizing conditions among adolescents and 
adults with HIV infection and should facilitate efforts to evaluate current and 
Type of Exposure Risk per 10,000 Exposures 
Parenteral 
Blood Transfusion 9,25 
Needle-Sharing During Injection Drug 
Use 
63 
Percutaneous (Needle-Stick) 23 
Sexual 
Receptive Anal Intercourse 138 
Insertive Anal Intercourse 11 
Receptive Penile-Vaginal Intercourse 8 
Insertive Penile-Vaginal Intercourse 4 
Table 4. Risk contacts and the associated probability of infection. Data 
fromhttps://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html 
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future health-care and referral needs for persons with HIV infection. The 
definition of AIDS includes all HIV-infected individuals with CD4 counts of 
<200 cells/µL (or CD4 percentage <14%) as well as those with certain HIV-
related conditions and symptoms. Although the fine points of the classification 
system rarely are used in the routine clinical management of HIV-infected 
patients, a working knowledge of the staging criteria (in particular, the 
definition of AIDS) is useful in patient care. In addition, the CDC system is used 
in clinical and epidemiologic research. This system replaces the classification 
system published in 1986, which included only clinical disease criteria and 
which was developed before the widespread use of CD4+ T-cell testing. 
In contrast to the CDC system, the WHO Clinical Staging and Disease 
Classification System (revised in 2007) can be used readily in resource-
constrained settings without access to CD4 cell count measurements or other 
diagnostic and laboratory testing methods. The WHO system classifies HIV 
disease on the basis of clinical manifestations that can be recognized and treated 
by clinicians in diverse settings, including resource-constrained settings, and by 
clinicians with varying levels of HIV expertise and training. 
1.5.  DIVERSITY OF HIV  GGGGGGGččččččččččččččččččččččččččččččččččččččč
One of the most important factors in the worldwide spread of HIV is its 
rapid evolution and enormous genetic variability. Its evolutionary rate is 
approximately one million times faster than higher organisms such as humans, 
meaning that the amount of changes within the HIV-1 genome in just one year 
corresponds to the amount of changes within the human genome in one million 
years.  
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A first investigation of HIV genome diversity indicated that the major 
reason for high sequence variation is the lack of proof reading and poor fidelity 
of HIV-1 Reverse transcriptase. Soon after, it became clear that this respresents 
only one of the several aspects of HIV diversity. Other members of the 
Retroviridae family, which have mutation rate similar to that of HIV-1, have a 
lower genetic variation because these viruses replicate less frequently in their 
hosts. The enormous genetic variation in HIV-1 in patients is primarily due to 
the very rapid turnover of a relatively large population of infected cells (Butler 
et al., 2007).  
The second evolutionary mechanism of HIV that is critical to its 
enormous genetic diversity is an unusually high recombination frequency. As 
with other retroviruses, HIV-1 recombines during reverse transcription (Butler 
et al., 2007). The HIV reverse transcriptase can utilize both copies of the co-
packaged viral genome in a process termed retroviral recombination. In 
addition to the obligatory strand transfers that occur at the ends of the genome, 
RT has been shown to switch between co-packaged RNA templates within 
internal regions of the genome, leading to formation of recombinant DNA 
molecules (Goodrich and Duesberg, 1990). It is now apparent that template 
switching occurs throughout the HIV genome and is much more frequent than 
mutation (Schlub et al., 2010). It has been estimated that HIV-1 undergoes 
recombination at a rate of 2.8 crossovers per genome per cycle. 
In addition, the high replication rate of the virus in combination with 
selective forces in the host environment further contributes to the genetic 
variation. As a consequence, an HIV-1 population within a person consists of a 
large number of genetically related but non identical viruses, a population 
structure that gives this pathogen an opportunity of rapid adaptation to 
changes in its environment. The quasispecies concept has often been used to 
describe the genetic variation of HIV populations, although it has been argued 
that not all requirements are completely fulfilled. The HIV quasispecies is 
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shaped at almost every stage of the virus life cycle. The clinical implications of 
the great genetic variability are extensive. It allows the virus to escape the host 
immune system survey, alowing drug resistance developng and escape 
candidate vaccines. Therefore, knowledge about the genetic variation of HIV-1 
is important for the drugs and vaccines design and for improving combination 
therapy. It can also help us to understand more the natural history and 
pathogenesis of the infection. 
Together with the founder effect genetic diversity of HIV has resulted in 
several genetically divergent lineages that can be classified into groups, 
subtypes and sub-subtypes based on their phylogenetic relationships. This 
classification also reflects important zoonotic transmission events.  
1.5.1 MOLECULAR “FOOTPRINTS” ON THE HIV 
GENOMEKKKKKKKKKKKKKKKKKKKK 
The HIV evolutionary process is driven by complex interplay between 
viral and host factors, leaving a measurable footprint in viral gene sequences 
(Lemey et al., 2006). Within hosts, the viral evolution is strongly influenced by 
natural selection as a result of a continuous effort to evade the immune 
response. HIV successively fixes mutations that allow it to evade immune 
response, acquiring combinations of polymorphisms in viral genome termed 
„molecular footprint“. For instance, previous work has shown that HLA alleles, 
in particular those alleles associated with effective immune control of HIV (viral 
evasion of CD8+ T-cell responses), such as HLA-B*57 and HLA-B*27, select a 
characteristic, predictable combination of escape mutations in the virus —
termed a “footprint” (Goulder et al., 2004; Kiepiela et al., 2007; Leslie et al., 2004;  
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McMichael and Klenerman, 2002). Several genetic polimorphisms, gene 
variants and number of certain genes have been studied and persistently 
related to HIV pathogenesis and disease progression. The most clearly defined 
footprints are those associated with HLA alleles that are linked with successful 
control of HIV, such as HLA-B*57 (Matthews et al., 2009; Kiepiela et al., 2007; 
Leslie et al., 2004). 
It is of paramount importance to investigate the extent to which HLA 
footprints impact on HIV phylogeny within a clade and these studies is still lacking, 
Evidence of favorable and unfavorable relationships of certain HLA-1 markers 
to virologic and immunologic outcomes of HIV infection is conclusive. HIV 
infection is one of only a few infectious diseases showing a clear-cut and 
consistent HLA association which has been confirmed by several genome wide 
association study (GWAS). 
Additionally, other viral features may have important influences on viral 
evolution, pathogenesis and disease outcomes, often through indirectly 
disturbing replicative capacity of virus, including resistance mutations to 
antiretroviral drugs and other mutations in different HIV-1 genes. The impact 
of positive selective pressure on virl diversity inter-host, as opposed to spatial 
and temporal factors, is not equally clear. 
A variety of statistical models and inference techniques have been 
developed to reconstruct the HIV evolutionary history and to investigate the 
population genetic processes that shape viral diversity. 
Investiation of the level of HIV genetic diversity observed within viral 
sequences could be complementary approach to antibody assays and surrogate 
epidemiolog ical definitions of recent infection. Viral diversity in individual 
patients is reflected in  the proportion of ambiguous bases observed in HIV-1 
pol sequences obtained from population based genotyping with increasing 
diversity seen with increased duration of infection (Kouyos  et al., 2011 ). 
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Ambiguous bases appear in sequences derived by population based sequencing 
due to the simultaneou s detection of more than one nucleotide at the same 
position of the genome. Viral 143 diversity has been used to estimate time since 
infection in HIV-1, 144 mainly subtype B infection (Kouyos et al., 2011 ) 
1.6.  HIV CLASSIFICATION  GLLLLLLLLLLLLLLLLLLLLLLLLLLL
JJJJ1.6.1   HIV TYPES, GROUPS AND SUBTYPES  
 Accurate HIV-1 subtyping information is vital for all kinds of HIV 
research. It gives insights into molecular epidemiology, viral evolution, and 
facilitates subtype-specific vaccine antigens and testing reagents. 
To date, two types of HIV have been identified; HIV type 1 (HIV-1) in 
1983 and HIV type 2 (HIV-2) in 1986 (Figure 5.). While HIV-1 is widely 
distributed throughout the world, HIV-2 infection is predominantly found in 
West African nations, such as Guinea-Bissau, Gambia, Senegal, Cape Verde, 
Cote d'Ivoire, Mali, Sierra Leone, and Nigeria. However, an increasing number 
of cases have been recognized in Europe (mainly in Portugal and France), India, 
and the United States, and other countries especially in those with historical 
and political ties to West Africa (Campbell-Yesufu and Gandhi, 2011).  
HIV-1 is the pandemic type and consists of 4 groups, groups M (main or 
major), non-M, non-O (N), outlier (O) and pending (P), each of which 
represents independent cross-species transmission events of Simian 
immunodeficiency virus (SIV) from chimpanzees (Pan troglodytes troglodytes) 
and gorillas (D’arc et al., 2015; Gao et al., 1999; Keele et al., 2006). This, together 
with human adaptation, accounts for their genomic, phylogenetic, and 
virological specificities (Mourez et al., 2013). . 
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Figure 5. Classification of HIV in types 1 (green) and 2 ( dark blue). HIV-1 is 
divided in groups M, N, O and P. The group M includes nine subtypes, subtype 
A and F are divided in subsubtypes e.g. A1 or F1. Some examples of circulating 
recombinant forms (CRFs) are shown in violet. HIV-2 is classified in eight 
groups (A-H), but only the most frequent groups A and B are shown. Modified 
from Tebit et al., 2011. 
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When represented on a phylogenetic tree strains within group M form 
well defined clusters (Figrue 5.). In the early 1990s the sequencing and 
alignment of viral genes env and gag from different strains of HIV-1 allowed 
for first time to establish the presence of well-defined HIV-1M genetic clades. 
Based on this information, subtypes A, B, C, D, E and F were recognized in 
1993. In 1994, subtypes G and H were characterized in Central Africa, and 
later subtypes I (1995), J (1999) and K (2000) were described (Janssens et al., 
1994; Kostrikis et al., 1995; Laukkanen et al., 1999; Triques et al., 2000; Peeters 
et al. 2013; Tongo et al., 2015). All HIV strains previously classified as subtype 
E based on env gene phylogeny had divergent subtype A classification 
in gag and pol, revealing that HIV-1 can generate inter-subtype recombinant 
strains. Indeed, a “pure” subtype E has not been found to date  (Gao et al., 
1996).  
According to the current classification, HIV-1 group M is divided into 
nine different “pure” subtypes or non-recombinant forms (A-D, F-H, J and K) 
(Robertson et al., 2000). Viral strains belonging to subtype A and F cluster 
distinctly into two different sub-lineages and therefore further divided into the 
sub-subtypes A1/A2 and F1/F2, respectively. For historical reasons the B and 
D clades are called subtypes, but in fact the genetic distance between these two 
clades corresponds to a sub-subtype distance. Additional taxonomic units 
include regional subepidemics (monophyletic clades), such as the B epidemic in 
Southeastern Asia, or the subtype A former Soviet Union, (variant Afsu) 
epidemic in PWIDs in former Soviet Union countries (FSU) (Bobkov et al., 1997; 
Bobkov et al., 2001; Deng et al., 2008). These taxonomic units correspond to sub-
epidemics in specific geographic areas forming monophyletic clusters within 
major HIV-1 clades (subtypes or CRFs). 
HIV-1 genomic diversity is the lowest within single patients and 
increases in the following order when different patients are considered: within 
subtypes, between subtypes, between groups and between HIV types (Li et al., 
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2015). A nucleotide genomic diversity was quantified to be 48.3% between HIV-
1 and HIV-2, 37.5% between HIV-1 groups, 14.7% between HIV-1 subtypes, 
8.2% within HIV-1 subtypes, and 0.6% within single patients infected with HIV-
1. (Li et al., 2015). The highest variation within the genome is seen within the 
env gene, whereas the pol gene, encoding for important viral enzymes are the 
most conserved (Gaschen et al., 2002; Lee et al., 2009). 
Group N has been identified in very few cases since its first description 
in 1998. With the exception of 1 case, all are documented in Cameroon  (Sharp 
and Hahn, 2011; Vallari et al., 2010; Mourez et al., 2013).  
Group O is limited to Cameroon and other adjacent countries 
representing less than 1% of HIV-1 infections (Bush et al., 2015; D’arc et al., 
2015; Leoy et al., 2015; Roques et al., 2002; Sharp and Hahn, 2011). Sporadic 
cases of HIV-O infection have been described in east and West Africa, Europe 
and the United States but always in Cameroonians or in patients with a link to 
Cameroon. 
 Group P was discovered in 2009 and, despite extensive screening, has 
been detected insofar in only two persons (D’arc et al., 2015; Mourez et al., 
2013). 
For HIV-2, the groups A-H are known but only groups A and B have 
infected substantial number of people in West Africa (Sharp et al., 2011; Ayouba 
et al., 2013; Visseaux et al., 2016). To date, no subtypes have been formally 
described but some preliminary data suggest that HIV-2 group A may be 
divided in two distinct subtypes with distinct geographical origins.  
To date only two recombinant forms have been described: one 
circulating recombinant form (CRF01_AB) and one unique recombinant form. 
Overall, HIV-2 group A predominates. HIV-2 group B is less prevalent and co-
circulates with HIV-2 A mainly in Ivory Coast and Ghana (Visseaux et al.,  
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2016). Nowadays, in West Africa, between 1 and 2 million people live with 
HIV-2 , but both its incidence and prevalence show decreasing trends probably 
because the transmission efficiency of HIV-2 is lower than that of HIV-1 
(Campbell-Yesufu and Gandhi, 2011; Tienen et al., 2010). 
Dual infections with HIV-1 and HIV-2 have been frequently observed in 
areas where both viruses co-circulate, but today no recombinant virus between 
HIV-1 and 2 has been documented yet. 
MMMMMMMMMLLKKKKKKKKKKK 1.6.2   HIV RECOMBINANTS
Other significant clusters are formed by Circulating Recombinant Forms 
(CRFs) and unique recombinant forms (URFs). Currently, more than 80 CRFs 
and numerous URFs have been reported 
(https://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html).Analys
es of multiple genome regions and in particular full-length genome sequencing 
have revealed that recombination between strains is a frequent occurrence. 
Recombinants between different HIV-1 group M subtypes are designated 
as either circulating recombinant forms (CRFs) if fully sequenced and found in 
three or more epidemiologically unlinked individuals or as unique recombinant 
forms (URFs) if not meeting these criteria. These have arisen as a result of 
recombination events between divergent HIV strains within individual hosts 
(http://www.hiv.lanl.gov). If a patient gets infected multiply with viruses from 
different subtypes, it can occasionally happen that two viruses recombine to a 
new viral strain with a mosaic genome composed of regions from both 
subtypes. Certain CRFs, like CRF01_AE and CRF02_AG, were already present 
early in the epidemic but many other CRFs emerged more recently. 
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MKKKKKKKKKKMML 1.6.3   DISTRIBUTION OF HIV-1 SUBTYPES
Geographical distribution of HIV-1 subtypes worldwide is complex and 
influenced by transmission risk behaviors and the patterns of human mobility. 
Among the four HIV-1 groups, only HIV-1 group M has spread worldwide. As 
the AIDS pandemic progresses, an increasingly broad range of genetic diversity 
is being reported within the M group of HIV-1 viruses (Gifford et al., 2007; 
Tongo et al., 2015)  
On a global scale, subtype C predominates representing almost half of 
HIV-1 infections (47%), followed in decreasing order by subtype A (27.2%), B 
(12.3%), and D (5.3%) (Hemelaar et al., 2006; Hemelaar et al., 2011; Osmanov et 
al., 2002). Other subtypes (F, H, J and K) and all other CRFs represented about 
5% of infections in the world (Figure 6.) (Hemelaar et al., 2011).  However, the 
global proportion of all CRFs increased by 4.5% in the recent years. 
The first HIV-1 subtype identified was subtype B, which is predominant 
in many resource-rich settings including North America, western and central 
Europe and Australia, along with other regions like the Caribbean and parts of 
Latin America, while subtype C is predominant in more resource-limited 
settings like Ethiopia, South Africa and India. Subtype B is most prevalent in 
the developed, industrialized regions of the world, and therefore a 
representative of this clade was used for development of antiretroviral drugs. 
When we look at the subtype distribution worldwide, we see that 
subtype C is almost exclusively responsible for all infections in Southern Africa, 
India and Ethiopia, responsible for 30, 13 and 4% of global infections 
respectively (Figure 5). Central Africa is thought to be the origin of all subtypes 
of HIV-1 (Hemelaar et al., 2011; Vidal et al., 2000) The initial diversification of 
group M viruses may have occurred within or near the territory of the 
Democratic Republic of Congo (DRC), which is considered as the epicenter 
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where the highest diversity of group M has been reported and from where the 
different HIV-1 M variants started to spread across Africa and subsequently to 
other continents in the world. A high genetic diversity is also seen in the 
surrounding countries like Cameroon, Angola, Central African Republic, Gabon 
and Equatorial Guinea. 
In West Africa, which harbors 16% of the global HIV-1 infections, 
subtype A, G and CRF02_AG are the most predominant. Subtype A, C, D and 
unique recombinant forms make up most of the HIV-1 infections in East Africa, 
which has 10% of global infections. Subtype A dominates the subtype diversity 
in Kenya, while subtypes D, C and G are responsible for most of the remaining 
infections. In Southern Africa, subtype C accounts for 92% of urban HIV cases 
while subtype B plays a minor role, with about 7% of cases (Williamson et al., 
2003). Subtype C is primarily transmitted heterosexually, and subtype B is 
associated with homosexual transmission (Bredell et al., 2000; Pillay et al., 2002). 
The majority of other subtypes in South Africa occur in immigrant populations 
from elsewhere in the continent (Bredell et al., 2002). 
CRF01_AE is responsible for most infections in South and South-East 
Asia (excluding India where subtype C is predominant), while in East Asia the 
burden of infections is caused by subtype B, CRF01_AE and other recombinants 
(Aldrich et al., 2012; Hemelaar et al., 2011). 
In Europe there are clear differences in geographical distribution and 
prevalence of HIV subtypes.  After the first introduction of subtype B in early 
80s, this clade is still predominat one in most Western and Central European 
countries ,whilst in Eastern Europe the epidemic has been dominated by 
subtype A (variant Afsu) (Eastern-type epidemic) (Abecasis et al., 2013; 
Hemelaar et al., 2011).  
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Figure 6.  Global distribution of HIV-1 subtypes and recombinants.  
Modified from (http://www.hivviralload.com) 
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However, in Europe the complexity of HIV-1 epidemic has been 
increasing during recent years. The cumulative number of diagnosed HIV-1 
infections in the European continent (i.e European Union, European Economic 
Area (EU/EEA), Russia and FSU countries) reached 1,840,136 by the end of 
2014 with 49% of these diagnosed in Russia, as reported by The European 
Surveillance System (TESSy), a joint ECDC/WHO database for HIV/AIDS 
surveillance ((ECDC), 2015) (Beloukas et al., 2016). Each country has a unique 
pattern of HIV-1 epidemic shaped by different regional circumstances and high 
prevalent local transmission networks with patterns varying between 
individual countries. Non-B epidemics are mainly associated with immigrants, 
heterosexuals and females but more recently, non-B clades have also spread 
amongst groups where non-B strains were previously absent - non-immigrant 
European populations and amongst men having sex with men (MSM). 
The subtype distribution in some of the Balkan countries (e.g. Croatia, 
Slovenia, Montenegro, Hungary, and Serbia) is similar to that in many of the 
Western and other European countries, whith the predomination of subtype B. 
On the other hand, subtype distribution of HIV-1 in Greece, Albania, and 
Bulgaria is marked by predominance of non B subtype (Figure 7) (Stanojevic et 
al., 2012). In Turkey, the prevalence of non-B clades is very high and include 
many different subtypes and CRFs. Unfortunately, the origin of these 
transmissions and/or local epidemics remains unclear. In Albania, local HIV-1 
epidemic is characterized by a high prevalence of non-B infections (65.2%) 
(Ciccozzi et al., 2005).  Specifically, spread of subtype A in Albania is a result of 
a founder effect from the A clade epidemic in neighboring Greece (Paraskevis et 
al., 2007; Salemi et al., 2008a). In Bulgaria, there are several HIV-1 subtypes 
circulating and, as it has been shown, clades B and A1 were introduced by at 
least three or four independent sources in last 25 years (Salemi et al., 2008b). 
Finally, in Romania, the HIV-1 epidemic is unique as the globally-rare subtype 
F1 predominates and any non-F1 subtypes are referred to as divergent strains. 
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Here, significant numbers of mainly institutionalized child ren were 
infected in the late 1980s via transfusion of infected blood products or unsafe 
parenteral treatments (Apetrei et al., 1997). Since 2010, an increasing trend of 
HIV-1 infections among people who inject drugs (PWID) has been observed, 
largely centered in Bucharest. Although F1 clade still predominates in the 
PWID epidemic, other clades, including CRF14_BG, have also been found 
(Niculescu et al., 2015). 
The time of the initial identification of the HIV-1 epidemics in the 
Balkans is comparable to the Western European countries. The first 
HIV-1/AIDS cases in the majority of countries were diagnosed in the beginning 
or mid-eighties, with the exception of Albania where the first case was 
registered in 1992. 
In Serbia, the predominance of subtype B was reported (in 87.5-91.2%) 
with other subtypes also appearing namely G (7.7%), C (4.4%) and CRF (1.8-
2.2%) (Stanojevic et al., 2012).  
Figure 7.  General distribution of HIV- 1 subtypes and recombinants in 
the Balkan region. Modified  from Stanojevic et al., 2012.  
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1.6.4 THE SIGNIFICANCE OF HIV-1 SUBTYPE 
DIVERSITYMKKKKKKKKK 
HIV-1 subtypes differ in biological characteristics that may affect 
pathogenicity and disease progression. Monitoring of subtypes distribution can 
give valuable information to a health care services with regards measures to 
sustain the epidemics and reduce onward transmission. Once of the major 
challenges of the subtype diversity might be on therapeutic and preventive 
management of the disease.  With ongoing generation of viral genetic diversity 
and potential for the emergence of novel genetic variants, it has become 
increasingly important to establish potential clinical implications of subtype 
variation. Some studies gave evidence that different subtypes may respond 
differently to drug therapy and found different rates of disease progression 
within HIV subtypes, while others suggested limited significance of differences 
among subtypes with regards development and clinical interpretation of 
antiviral resistance (Camacho and Vandamme,2007; Easterbrook et al., 2010; 
Kantor, 2006; Vijver et al., 2006).  
An important problem extensively discussed in the recent years relies 
on the impact of ARV drugs in different HIV-1 subtypes. This concern is 
based on the fact that the great majority of the investigations conducted on 
HIV drug design, acquisition of drug resistance mutations, genotyping for 
drug resistance evaluation, and the phenotypic impact of drug resistance 
mutation (DRM) on HAART have been performed primarily for subtype B 
strains. 
Various non-B HIV-1 group M subtypes present genetic signatures and 
polymorphisms in their protease gene which are considered as compensatory 
DRM in subtype B. These differences have triggered discussions as to 
whether those non-B subtypes are naturally less susceptible to PIs, which 
could in turn compromise the use of PI-containing HAART regimens. Upon 
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antiretroviral treatment, such differences in baseline polymorphisms among 
subtypes may result in the evolution of drug resistance along distinct 
mutational pathways, or in differences in the incidence of these specific 
pathways. These genetic differences may be clinically relevant when 
considering long-term treatment strategies for patients infected with different 
subtypes. 
ANALYSES OF HIV USING PHYLOGENETICSKKKKKćććććććKKKKK1.7.   
Phylogenies are important for addressing various biological questions 
such as relationships among species or genes, the origin and spread of viral 
infection and the demographic changes and migration patterns of species. 
Molecular phylogeny is the science of estimating evolutionary histories 
using DNA and amino acid sequences. Before the advent of DNA sequencing 
technologies, phylogenetic trees were used almost exclusively to describe 
relationships among species in systematics and taxonomy. The advancement of 
sequencing technologies has taken phylogenetic analysis to a new height. 
Today, phylogenies are used in almost every branch of biology.  
A phylogeny is an evolutionary tree in which the leaves of the tree are 
the sampled sequences or taxa, branches are the genetic distance between taxa, 
and the nodes denote estimated separation events events. Reconstruction of 
phylogenies can be accomplished through a variety of methodological 
approaches including neighbor joining (NJ), maximum likelihood (ML), and 
Bayesian methods that are described in detail in Chapter 3.  
 In On the Origin of Species in 1859, Charles Darwin first proposed the 
phylogenetic tree as a structure to describe the evolution of different organisms. 
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The tree structure is currently the accepted paradigm to represent evolutionary 
relationships between organisms, species or other taxa. A phylogenetic tree is a 
geographical representation of the evolutionary relationships that exist between 
aligned sequences (Maddison, 2000; Whelan et al., 2017). Once a phylogenetic 
tree has been constructed, any characteristic of the related organisms can be 
analyzed in the evolutionary framework specified by the tree. Changes in such 
characteristics (“characters”) can be inferred between descendent organisms 
and their ancestors—even if those ancestors were never observed directly 
(Maddison and Maddison, 2000). The first step in any phylogenetic 
investigation of evolutionary history is the identification of homologous 
sequences. Once a tree has been created there are many programs available for 
viewing and analyzing the tree topology (described in detail in Chapter 3.) 
(Whelan et al., 2017). 
 Historically, the case of the dentist and his patients who have been 
infected with HIV-1 in Florida was one of the first with regard to transmission 
investigation (Abele and DeBry, 1992; Palca, 1992a, 1992b). Shortly after, 
phylogenetics became an important tool for HIV research, that offers 
opportunities to understand critical aspects of the HIV epidemic. The 
application of molecular phylogenetics has become a common practice of many 
HIV/AIDS research studies, due mainly to the many insights these analyses can 
provide and the novel questions they can address over a variety of topics 
related to HIV biology. Together with population genetics and epidemiological 
principles, nowadays scientists are using viral phylogenetic to improve our 
understanding of HIV diversity, generating an unprecedented knowledge of 
viral dynamics to improve strategies of HIV prevention and treatment of HIV 
infected persons. 
Phylogenetic analyses have been used extensively in the studies of HIV-
1, and have proven to be an invaluable tool, revealing important aspects of 
evolution, origins, disease progression, and transmission of this virus. To date, 
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the application of phylogenetic analysis to the study of HIV has elucidated the 
origin of HIV-1 and HIV-2, the relationships of HIV to other simian lentiviruses, 
for characterizing HIV-1 genetic heterogeneity (i.e. molecular surveillance, 
phylogenetic classification into groups, subtypes, sub-subtypes, recombinant 
forms) and spatiotemporal characteristics (Castro-Nallar et al.,2012; Robbins et 
al., 2003). Phylogenetic tools brought to light dimensions of HIV evolution such 
as “where and when” and even “how” infections are spreading worldwide that 
are impossible to assess with other approaches. Phylogenetic analyses have also 
been key to the identification of drug-resistance mutational transmission chains. 
(Lemey et al., 2005; Machado et al., 2009). 
1.7.1 ANALYSES OF HIV ORIGIN USING PHYLOGENETIC 
Nowadays, it is still not known how many people became infected with 
HIV before the initial recognition of AIDS in the USA in the early 1980s. 
However, it is clear, that before its discovery the virus silently spread to at least 
five continents of the world and it has been suggested that at least 100 000-300 
000 persons were infected. Molecular analyses of stored serum sample and 
lymph node biopsy specimen collected in 1959 and 1960, respectively, in 
Democratic Republic of Congo (DRC) showed seropositive results for HIV (Zhu 
et al., 1998). 
A year after the first identification of HIV-1 as the cause of AIDS, the first 
Simian lentivirus, SIVmac, was isolated from captive rhesus macaques (Macaca 
mulatta) at the New England Primate Research Center (NEPRC) (Chakrabarti et 
al., 1987; Daniel et al., 1988; Li et al., 1989). These infected macaques developed 
symptoms very similar to AIDS in humans and soon the simian origin of AIDS 
was suspected. Thereafter, it became clear that macaques are not natural hosts 
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of virus but became infected with SIVsmm from captive sooty mangabeys that 
are naturally infected with this virus. (Fultz et al., 1986; Apetrei et al., 2005).  
Today, more than 40 SIVs have been identified in different non human 
primates (NHP) species from Africa. SIVs are named according to the host 
species, and a three letter code refers to the common name of the corresponding 
NHP species. 
Phylogenetic investigations have shown that HIV originated from 
multiple crosspieces transmissions from NHP that had taken place long before 
the first diagnoses (Figure 8.) (Keele et al., 2006; Sharp and Hahn, 2011; Van 
Heuverswyn et al., 2006). The most recent ancestor of the pandemic strain was 
probably circulating in human populations in Central Africa early in the 20th 
century (Faria et al., 2014; Korber et al., 2000; Worobey et al., 2008). Already 
thirteen transmissions involving three different NHP species to humans have 
been documented, four for HIV-1 and nine for HIV-2. 
How the virus crossed from NHP to humans is still debated, but the 
most accepted theory is the so called „hunter theory“. These zoonotic 
transmissions probably happened during the hunting and butchering of 
primates for bush meat, as well as the capture, trade and keeping of monkeys as 
pets (Hahn et al., 2000). Through studies of phylogentics, it was found that 
HIV-1 is most closely related to Simian immunodeficiency virus (SIVcpz) which 
is found in the chimpanzee sub-species Pan troglodytes troglodytes (Gao et al., 
1999, Korber et al., 200, Yusim et al., 2001).  Even though SIVcpz was also found 
in the eastern chimpanzee subspecies (Pan troglodytes schweinfurthii), virus from 
this group does not appear to have jumped successfully into humans (Santiago 
et al., 2002). Extensive analyses of fecal samples of wild chimpanzees suggested 
to the origin of HIV-1 group M in southeastern Cameroon and HIV-1 group N 
in south central Cameroon (Keele et al., 2006). HIV-1 groups O and P originated 
from SIVgor identified in Western lowland gorillas living in Cameroon.   
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Figure 8. Cross-species transmission of HIV and distribution of subtypes  
and recombinant forms.  
Modified from Tebit et al., 2011 
  
45  
 
 HIV–1 IN SERBIA 
 
Using the molecular clock dating analyses, the time of the Most Recent 
Common Ancestor (tMRCA) of the pandemic HIV-1 group M was initially 
dated back to 1931 (1915-1941) (Korber et al., 2000). However, after the 
identification of the oldest HIV-1 viruses ZR59 and DRC60 from the DRC and 
inclusion of these viral sequences in the analysis, the tMRCA (using 
phylogenetic methid Bayesian skyline plot tree prior) has been pushed back 
slightly to 1908 (1884–1924) (Worobey M et al., 2008; Zhu et al., 1998). Both HIV-
1 group M and O dates were inferred using a relaxed molecular clock, which 
allows the rate of evolution to vary along different branches of the tree. The 
tMRCA of O and N group was estimated at 1920 (1890– 1940) and 1963 (1948–
1977) respectively (Lemey et al., 2004; Wertheim et al., 2009 HIV-2 group A and 
B tMRCAs were estimated to be 1940 (1924–1956) and 1945 (1931–1959), 
respectively (Lemey et al., 2003). These dates were estimated using a strict 
molecular clock, (i.e., a single, constant evolutionary rate along all branches) 
(Lemey et al., 2003). 
By analyzing viral sequences obtained over several decades, Faria et al., 
used Bayesian skyline plot analyses and estimated that between 1920 and 1960, 
group M underwent an early phase of relatively slow exponential growth. 
Further analyses showed that, around 1960 (95% BCI: 1952–1968) group M 
transitioned to a second, faster phase of exponential growth. Although the 
TMRCA of group O is similar to that of group M and both grew at similar rates 
until ~1960, group O exhibits no subsequent increase in growth rate and 
remains largely confined to Cameroon and surrounding countries (Figure 9). 
After the initial cross-species transmission, that took place in southern 
Cameroon, presumably resulting from the hunting of primates, group M 
viruses most likely entered Kinshasa, the capital of the Democratic Republic of 
Congo, around 1920 (1909–1930) (Keele et al., 2006; Faria et al., 2014). In that 
time, Cameroon was under German colonization and fluvial connections 
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between southern Cameroon and Kinshasa were frequent due to the 
exploitation of rubber and ivory. After localized transmission in Kinshasa, the 
virus probably reached large neighboring cities, such as Brazzaville, 
Lubumbashi, and Mbuji-Mayi within about 20 years (Figure 10.) (Faria et al., 
2014). 
 
 
  
 The changing behavior of sex workers, urban growth and human 
mobility by railway connections play fundamental roles in the early spread of 
the virus and may explain the linkage among these cities (Faria et al., 2014; 
Hahn et al., 2000; Worobey et al., 2008). Crucial factor responsible for 
dissemination of both HIV-1 and HIV-2 worldwide was the intense migration 
of individuals, from rural to urban centers with subsequent return migration 
and internationally due to civil wars, tourism, business purposes, and the drug 
trade. The migration of poor, rural, sexually active young people to urban 
centers in the Third World clearly played a role in the dissemination of HIV and 
other infectious diseases 
Figure 9. Population dynamics of HIV-1 groups M and O obtained by 
Bayesian skyline plot analyses. Modified from Faria et al., 2014. 
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Many studies, dealing with a phylogenetic origin of HIV, were based on 
a specific mechanism which facilitate the first few serial transmissions of the 
virus in humans, while largely limit the problem of initial adaptation 
(Gisselquist, 2003; Marx et al., 2001). Recent research proposed a major role of 
genital ulcer diseases (GUD), such as syphilis, chancroid, and 
lymphogranuloma venereum (LGV), and possibly also a relatively low 
frequency of male circumcision, in initial HIV transmission and adaptation to 
Figure 10. Spatial spread of HIV-1 group M. Modified from Faria et al., 2014. 
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humans (de Sousa et al., 2010). GUD induced genital ulcers can dramatically 
increase HIV transmission, and this research suggested that the high prevalence 
of these diseases might have provided crucial “help” for the initial spread of the 
virus. GUD and especially syphilis induces a potent inflammatory response, 
and tumor-necrosis-factor (TNF)-α production, which is a major enhancer of 
HIV replication (de Sousa et al., 2010; de Sousa et al., 2012). 
 
1.7.2  ANALYSES OF HIV TRANSMISSION CHAINS KKKKKK  
DNA sequencing and molecular phylogenetics are increasingly being 
used in virology laboratories to study the transmission of viruses. In the field of 
molecular epidemiology it is considered that epidemiologically related 
sequences should group together in a phylogenetic tree, forming transmission 
clusters, because they all share a common, recent ancestor (Hue et al., 2004; Hue 
et al., 2005). HIV phylogenetics requires the generation of viral sequences, 
which in most cases are derived from virions isolated from the peripheral blood 
of infected persons with unknown duration of disease. Analysis of HIV 
nucleotide sequence data can be used to identify individuals with highly similar 
HIV strains and understand transmission. As HIV-1 is a fast evolving organism, 
it will accumulate mutations within reasonable amount of time, and 
simultaneously preserve some common signature patterns with its ancestors, 
such that genetic relationships between viruses within and among patients can 
be reconstructed in phylogenetic trees. For instance, several studies have 
demonstrated the presence of phylogenetic clusters of highly related HIV-1 
sequences, particularly among recently HIV-infected individuals, which have 
been used to argue for a high transmission rate during acute infection.  
Identification HIV clusters could be useful in tracking the leading edge of 
HIV transmission in epidemics. Analysis of HIV clusters could provide 
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valuable information for understanding the structure and dynamics of HIV 
transmission networks. If the virus is phylogenetically tightly clustered, it is an 
indication that the hosts are connected by a short chain of transmissions. 
Definitions of phylogenetic transmission clusters vary widely in the HIV 
literature, though many studies use both clade support and genetic distance 
cutoffs. 
In addition, phylogenetic analyses have also been used to supplement 
evidence in criminal investigations of HIV transmission (de Oliveira et al., 2006; 
Saludes et al., 2013; Scaduto et al, 2010; González-Candelas et al., 2003; 
González-Candelas et al., 2013). Transmission of HIV between individuals may 
have important legal implications, therefore requiring forensic investigation, as 
for example when it occurs as implication of inappropriate medical practice or 
unprotected sex with a person aware of his/her infection status (Abecasis et al., 
2011)). 
DNA fingerprinting is a widely-accepted technique employed by 
forensic scientists as a means of matching individuals’ respective DNA profiles 
(Jobling et al., 2004). Unlike DNA fingerprinting, phylogenetic analysis is a 
technique to compare how closely DNA sequences from different sources are 
related (Baxevanis et al., 2001). When using HIV phylogenetic analysis for 
forensic purpose, investigators are often warned to be cautious (Bernard et al., 
2007). In fact, even if the strains carried by two subjects are more related to each 
other than the control strains, the following circumstances could not be 
excluded: both subjects were infected by one or more third parties with similar 
viruses, or a third party mediated HIV transmission from one subject to the 
other. Thus, phylogenetic analysis can and does include a certain degree of 
approximation and error. Phylogenetic evidence, in the context of other clinical 
and epidemiological evidence, can provide support for linkage between cases, 
but cannot be proof of transmission by itself (Bernard et al., 2007).  
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For forensic investigation based on phylogenetic analyses, at least two 
independent samples need to be blindly tested at two different time points, and 
the results between the time points should be consistent (Bernard et al., 2007). 
In order to give strong forensic evidence regarding transmission, phylogenetic 
analysis needs to be enhanced with application of several methods and 
conducted under strictly controlled conditions (Bernard et al., 2007; Leitner et 
al., 2000). Firstly, it is vitally important for phylogenetic analysis to include 
adequate local controls that are viral sequences from infected individuals 
sharing the same transmission risk, from similar geographic location, of the 
same genetic clades (subtype or recombinant form), and diagnosed in the same 
time period as the query subjects, but who are not believed to be a part of the 
investigated outbrake.  The use of inappropriate controls could overemphasize 
the relatedness between the viruses under study as being uncommonly unique 
(Leitner et al., 2000). However, it is never possible to sample all infected 
individuals in a population.. Nevertheless, if sufficient number of local control 
sequences is included in the analyses, significant clustering of sequences under 
investigation can indicate that they do belong to a transmission chain. Secondly, 
apart from appropriate local controls, additional precondition in applying 
forensic phylogenetic is inclusion into the analysis at least two genetic regions 
of reasonable length, depending on the gene under investigation. There are 
many different phylogenetic tree buiding methods that could be used within 
forensic research, and the choice is based on their reliability. Current techniques 
are not reliable enough to estimate the direction of transmission. Several studies 
is being done in this area, but for this purpose, multiple samples would need to 
be obtained very soon after the presumed transmission event between subjects 
included in the forensic investigation. In this research, end point limiting 
dilution (EPLD) assay was performed to access different subpopulations of HIV 
quasispecies, thus, improving the range of the quasispecies detection.
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Molecular and phylogenetic analyses have inherent limitations, and are 
subject to issues that are associated with sampling and methods. More broadly, 
limitations include the paucity of molecular sequences or inadequate data 
(related not only to primary sequence data but also to demographics and 
additional parameters), which are common in resource-limited countries and 
settings (which often represent the greater burden of HIV disease), the non-
representative nature of data, partial or incomplete phylogenetic signal in 
nucleotide sequences, and non-existence of reference datasets. HIV sequencing 
technology is rapidly changing, and it is critical to understand the advantages 
and limitations of the different sequencing technologies available prior to 
performing phylogenetic studies. Methodologically, the underlying 
assumptions, specific methods, and models used, coupled with computation 
time, and size of datasets (analyses on large datasets using computationally 
intensive methods cannot converge in reasonable time sometime) serve as 
limitations. Lastly, ethical issues around the confidentiality, particularly in the 
context of identifying networks of HIV transmission, have to be carefully 
considered by public health officials and researchers. 
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The general aim of this research was to investigate genetic diversity and molecular 
phylogeny of circulating HIV strains in Serbia based on samples collected from 2008 to 
2013 and compares it to previous data in order to better understand local HIV 
epidemic spread. 
 
 
Specific aims of the study included: 
 
 
1. To describe and characterize current prevalence and distribution of 
subtypes and circulating recombinant forms in Serbia. 
 
2. To investigate and characterize local transmission networks as well as to 
phylogenetically estimate the time of the most recent common ancestor 
(tMRCA) of the main HIV-1 clades in Serbia. 
 
3. To analyses the prevalence and patterns of viral DNA sequence changes 
as markers of duration of infection and host-virus interaction. 
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3.1.  STUDY DESIGN AND ETHICAL APPROVAL  LLJJJJJJJJJJJJJJJJJJJJJJLLL
The study was designed to be cross-sectional, molecular and 
phylogenetic investigation of HIV-1 diversity. It was conducted at the Institute 
of Microbiology and Immunology, of the School of Medicine, University of 
Belgrade. Before the start of the research, the protocol was approved by the 
Ethical Comitee of the School of Medicine, University of Belgrade. Patients were 
informed of the objectives of the study and participants were included upon 
informed consent. The proposed eligibility criteria for participant selection 
included: HIV-1 seropositive adults (men and non-pregnant women) aged 18 
years or above, both treatment naive and treatment experienced (patients on 
HAART) and viral load higher than 1000 copies per ml of blood.  
Epidemiological, clinical and virological data were collected using a 
comprehensive standardized questionnaire. Transmission risk was categorized 
as men who have sex with men (MSM), heterosexual, intravenous drug use 
(IDU), transfusion, vertical transmission or unknown. For patients reporting 
IDU in addition to another risk, the former was considered as main risk for 
acquiring HIV infection. 
3.2. STUDY SUBJECTS AND SAMPLE COLLECTIONKKKKKKKKKKKKK 
The study included 155 consenting, HIV infected patients, both male and 
female, who fulfilled the inclusion criteria of the study. Blood samples used in 
the study were collected from 2008 to 2013 from patients who were referred to 
the Center for HIV/AIDS, University Hospital for Infectious and Tropical 
Diseases, Clinical Centre of Sebia, Belgrade. In addition, 162 HIV-1 sequences 
from Serbian patients, retrieved from
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the NCBI database, sampled and deposited in the period from 1997 to 2007, 
were also included. 
 
Using a sterile syringe and a needle, ten-milliliter of venous blood samples 
were collected in Ethylenediaminetetraacetic acid (EDTA) tubes Vacutainer 
(BD) and immediately transported at 4ºC. These samples were transported to 
the Institute of Microbiology and Immunology, Virology Department, for 
processing. Upon arrival, peripheral blood mononuclear cells (PBMC) and 
plasma was separated by centrifugation at 5000 rpm (~ 370 x g) for 15 minutes 
and preserved at −80 ◦C for further molecular analyses.  
Within this study a forensic analysis was performed in order to infer 
genetic relatedness and explore suspected epidemiological linkage between 
HIV genome sequences isolated from three HIV-1 infected patients. Three 
patients, fulfilling the inclusion criteria: a man (subject 1) and two women 
(subject 2 and subject 3), all coming from the capital city of Belgrade, were HIV 
diagnosed at the Center for HIV/AIDS, University Hospital for Infectious and 
Tropical Diseases in Belgrade, Serbia, in August and September 2011. A priori 
information were as follows: (i) subject 1 and subject 2 had been married for 
over 15 years with two kids aged 10 and 14, both found to be HIV negative; (ii) 
subject 3 was sexual partner of subject 1 and together they had several 
prolonged sojourns in Thailand in years preceding HIV infection diagnosis of 
all three patients; (iii) finally, subject 1 sued subject 3 for knowingly infecting 
him, without disclosing her HIV status. 
3.3. RNA EXTRACTION FROM PLASMA SAMPLES  LLKKKKKKKKKKKL
RNA was extracted from plasma samples using QIAamp Viral RNA 
Mini Kit (Qiagen, Hilden, Germany) according to manufacturer’s instructions. 
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Prior to RNA extraction a total of 1.5 mL of each plasma sample was 
centrifuged for 1.30 h at 4 C at 22,000 g. The supernatant was carefully removed 
to the volume of 140 µl, and the pellet was resuspended, and used for RNA-
extraction.  
Briefly, 140 μl of plasma was put into 560 μl of RNA viral lysis buffer 
(Buffer AVL) containing carrier RNA and vortexed for 15 seconds and 
incubated for 10 minutes at room temperature. This mixture was briefly 
centrifuged and 560 μl of ethanol was added, pulse vortexed and centrifuged. 
Approximately 630 μl of the solution was applied to QIAamp spin column in 2 
ml collection tube without wetting the rim and centrifuged for 1 minute at 
8000x rpm. The collection tube containing filtrate was discarded. To this 
column, 500 μl of wash buffer 1 (Buffer AW1) was then added and centrifuged 
for 1 minute at 8000x rpm. Further, the column was placed in a clean 2 ml 
collection tube and filtrate discarded. About 500 μl of wash buffer 2 (Buffer 
AW2) was added to the collecting tube, cap was closed, and centrifuged at 
maximum speed (14500x rpm) for 3 minutes. This procedure was repeated at 
the same speed for 1 min in order to remove any wash buffer carryovers. The 
QIAamp spin column was placed in a clean 1.5 ml microcentrifuge tube and 60 
μl of elution buffer was added. This was incubated at room temperature for 1 
minute and finally centrifuged at 8000x rpm for 1 minute to elute the RNA. The 
yielded viral RNA was stored at -80°C for later use in Reverse transcriptase 
polymerase chain reaction (RT–PCR). 
3.4. DNA EXTRACTION FROM PBMCsLLLLLLLLLLLLKKKKKKKKKKKK 
After the separation of PBMCs, DNA extraction was done using QIAamp 
DNA Blood Mini kit (Qiagen, Hidden, Germany), as per manufacturer’s 
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protocol. Briefly, 20 µl of QIAGEN Protease (proteinase K) was pipetted into a 
sterile microfuge tube and 200 µl of samples was added to the same tube. 
Further 200 µl of the lysis buffer (Buffer AL) was added to each sample and 
mixed thoroughly by pulse-vortexing for 15 sec. The tube was then incubated at 
56oC for 10 minutes to lyse the cells. In the following step 96% ethanol was 
added to the sample, and mixed again by pulse-vortexing for 15 sec. This 
mixture was further carefully applied on the top of the QIAamp Mini spin 
column (in a 2 ml collection tube), and centrifuged at 6000 x g (8000 rpm) for 1 
min. To this column, 500 μl of wash buffer 1 (Buffer AW1) was then added and 
centrifuged for 1 minute at the same at the same speed as in the preceding step. 
Further, the column was placed in a clean 2 ml collection tube and filtrate was 
discarded. About 500 μl of wash buffer 2 (Buffer AW2) was added on the top of 
the QIAamp Mini spin column, cap was closed and centrifuged at maximum 
speed (14500x rpm) for 3 minutes. The QIAamp Mini spin column was placed 
in sterile 1.5 ml microfuge tube and the collection tube containing the filtrate 
was discarded. The QIAamp spin column was opened carefully and 50 µl of 
elution buffer (Buffer AE) was added. The tube was incubated at room 
temperature for 1 min, and then centrifuged at 6000 x g (8000 rpm) for 1 min. 
Extracted DNA was stored in AE buffer (provided by QIAamp DNA Mini Kit) 
at - 20oC until further usage. 
3.5. NESTED POLYMERASE CHAIN REACTIONLLLLLLLLLLLLLLLLLLLL 
The starting template for genotypic reverse transcriptase polymerase 
chain reaction (RT-PCR) was RNA extracted from plasma, for both pol and env 
regions. All reagents were thawed and put on ice. The list of PCR primers used 
in this study are indicated in the Table 5. For the first round of the PCR assays 
(outer PCR), RNA was reverse transcribed using a One Step RNA PCR Kit 
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(Qiagen, Hilden, Germany). Reactions were set up on ice in a UV-treated 
laminar flow hood. Reaction mix and cycling parameters were typically as per 
manufacturer’s instructions although optimization of annealing temperature 
was occasionally necessary.  
 
Standard conditions were: 
 
 8 µl of 5x  OneStep RT-PCR Buffer 
 1,6 µl of dNTP mix 
 1.6 µl of Fw primer in 0.6 µM final concentration (Invitrogen by Life 
Technologies, Carlsbad, California, USA) (Table 5.) 
 1.6 µl of Rev primer in 0.6 µM final concentration (Invitrogen by Life 
Technologies, Carlsbad, California, USA) (Table 5.) 
 15.6 µl of Rnase-free water 
 10 µl of isolated RNA template. 
 
Final  reaction volume was 40μl.  
 
Prior to PCR lyophilized primers were resuspended in sterile distilled 
water to a stock concentration of 100 pmol/µl. Primers used for 
amplifications were equilibrated to working concentrations of 20 pmol/µl. 
Primers were stored at -20 °C until required. 
In the thermal cycler “Eppendorf Mastercycler ep gradient S”samples 
were initially reverse transcribed at 50°C for 40 minutes and then denatured 
at 94°C for 15 minutes. After an initial denaturation step the cycling begins 
with a short denaturation at 94°C for 30 sec the primers were annealed for 1 
minute at an appropriate temperature, according to the melting temperature 
of the primers and the template, followed by an extension time of 3 minute 
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at 72 ºC. This cycle was repeated 35-40 times and followed by a final 
elongation step of 10 minutes at 72 ºC.  
First round of one step RT-PCR assay was followed by second round 
(inner PCR), using Thermo scientific dream taq PCR master mix (2X) 
(Applied Biosystem, Foster City, California). In summary, 5 µl product from 
first round PCR was used as a starting template for a second round.  
 
General protocol was as follows:  
 
 25 µl of DreamTaq PCR Master Mix (2X) 
 1 µl of Fw primer in 0.6 µM final concentration (Invitrogen by Life 
Technologies, Carlsbad, California, USA) (Table 5.) 
 1. µl of Rev primer in 0.6 µM final concentration (Invitrogen by Life 
Technologies, Carlsbad, California, USA) (Table 5.) 
 18 µl of nuclease free water 
 5 µl of outer DNA template 
 
Final reaction volume was  50μl. 
 
In the thermal cycler “Eppendorf Mastercycler ep gradient S” after an 
initial denaturation step on 95°C for 3 min, the cycling begins with a short 
denaturation at 95°C for 30 sec, the primers were annealed for 45 sec at an 
appropriate temperature, according to the melting temperature of the primers 
and the template (Table 5.), followed by an extension time of 3 minute at 72 ºC. 
This cycle was repeated 40 times and followed by a final elongation step of 10 
minutes at 72 ºC.  
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Table 5. Table of primer pairs used in nested PCR and cycle sequencing 
reaction with melting temperature (Tm) of each primer calculated by Tm 
calculator  (Snoeck et al., 2005; McGovern et al., 2010) 
 
 
 
pol gene Tm env gene  Tm 
OUTER 
PRIMERS 
(5′-3′ direction) 
 GGTTAAATAAAATAGTAAG  550C GAGCCAATTCCCATACATTATTGT 580C 
ATTGTTTTACATCATTAGTGTG 530C GCCCATGTGTTCCTGCTGCTCCCAAGAACC 600C 
INNER 
PRIMERS 
(5′-3′ direction) 
GTACACTAGAAGAAATGATGAC 580C TGTCCCCAGCTGGTTTTGCGAT 600C 
CCGATAAATTTGATATGTCCATTG 560C TATAATTCACTTCTCCAATTGTCC 570C 
SEQUENCING 
PRIMERS 
(5′-3′ direction) 
GGCAAATACTGGAGTATTGTATGCA 550C 
AATGTCAGYACAGTACAATGTACAC 550C 
CCTGTCAACATAAT 550C 
TACTAGGTATGGTAAATGCAGT 550C 
GAAAAATTCCCTTCCACAATTAAA 530C 
  CAGTACTGGATGTGGGTGATG 550C 
 
3.5.1 END POINT LIMITING DILUTION POLYMERASE CHAIN 
REACTION (EPLD – PCR)KKKKKKKK 
Phylogenetic analyses of query viral sequences for forensic purpose 
included viral RNA  extracted from 140 µL of plasma using the QIAamp Viral 
RNA Kit (Qiagen, Hilden, Germany), as described in detail above. Two step RT 
PCR was performed on a 20-µL volume containing 10 µL of eluted RNA using 
Qiagen Long range 2-step RT PCR kit (Qiagen, Hilden, Germany). EPLD-PCR is 
an assay that is basd on serial dilutions of nucleic acid (template for PCR) to the 
point that precedes the dilution that gives a negative PCR result. Conditions can 
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be manipulated to access different subpopulations of HIV quasispecies, thus, 
improving the range of the quasispecies detection.  
After reverse transcription of viral RNA, complementary DNA (cDNA) 
was diluted by end point limiting-dilution (EPLD) procedure and further PCR 
amplified using primer pairs as described in (Table 5).  For three query samples 
a minimum of five repeats of end point three-fold limiting-dilution PCR 
reactions (EPLD-PCR) were performed, starting from reverse transcription 
obtained cDNA. Extraction of proviral DNA, was also included of this part of 
research based on manufacturer’s protocol as described above. Prior to nested 
PCR assay, DNA eluate was diluted by EPLD procedure. 
3.6. AGAROSE GEL ELECTROPHORESISkkkkkkkkkkkkkkkkkkkkkkkkkk 
Conventional agarose gel electrophoresis was used to analyze all PCR 
products. In order to analyze PCR products of pol and env gen, 2 % agarose was 
prepared. All agarose gels were stained with ethidium bromide stock solution 
(1 μg/ml) for visualization of the DNA bands. Ethidium bromide is a powerful 
mutagen and should be handled carefully.TAE (Tris-acetate-EDTA) buffer was 
used as both a running buffer and in agarose gel (Sambrook et al., 1989). TAE 
buffer, is commonly prepared as a 50X stock solution for laboratory use. This 
stock solution can be diluted 50:1 with water to make a 1X working solution. 
This 1X solution will contain 40mM Tris, 20mM acetic acid, and 1mM EDTA. 
Samples were mixed with 2 µl of the gel loading dye (0.125% Bromophenol 
blue, 40% Sucrose) and approximately 8 μl were the loaded per lane on agarose 
gel. The Gene RulerTM 1 kb DNA ladder (DNA Standard 100bp - Serva 
Electrophoresis GmBH, Heidelberg,) was used as a molecular length size 
marker. Electrophoresis reactions were run at 120 V. The DNA bands were 
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visualized on a UV transilluminator under a UV light with a wavelength 
between 280 and 320 nm. 
3.7.  CYCLE SEQUENCING REACTIONlllllllllllllllllllllllllllllllllllllllllllllllllll 
3.7.1  PURIFICATION OF PCR PRODUCTS 
To dispose of excess dNTPs, enzymes and buffers, amplified PCR 
products, which showed a clear band on the agarose gel, were purified with 
MinElute Purification Kit (Qiagen, Hilden, Germany) kit, using the 
manufacturer’s instructions. The purification protocol based on silica 
membrane spin was used, which allows binding of nucleic acids to a silica 
membrane inside a spin column (Sambrook et al., 1989).  
General protocol was as follows 
 Firstly, 200 µl of Buffer PB and 40 µl product of nested PCR 
reaction were roughly mixed and applied to MinElute column and 
centrifuge for 1 min at 18000 x g. Flow-through was discarded and 
the MinElute column was put back into the same collection tube. 
 Secondly, 750 µl Buffer PE was to the MinElute column and 
centrifuge for 1 min at 18000 x g. Once again . Flow-through was 
discarded and the MinElute column was put back into the same 
collection tube. The column was centrifuged for an additional 1 
min at maximum speed. 
 Lastly, MinElute column was placed in a clean 1.5 ml 
microcentrifuge tube. 10 µl Buffer EB (10 mM Tris·Cl, pH 8.5) was 
added to the center of the membrane,  and let the column stand 
for 1 min, and then centrifuge for 1 min at 18000 x g. 
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3.7.2  CHAIN TERMINATION SEQUENCING REACTION 
Purified PCR products were subjected to direct sequencing of both the 
sense (forward) and antisense strands (reverse). DNA sequencing was carried 
out using the Sanger cycle sequencing method. Sanger sequencing is based on 
the selective incorporation of chain-terminating dideoxynucleotides by DNA 
polymerase during in vitro DNA replication (Sanger et al, 1977). Chain 
termination sequencing reactions were set up in house, using BigDye 
Terminator v3.1. Cycle Sequencing kit (Applied Biosystems Incorporated, 
Foster City, CA) according to manufacturer’s instructions. Fluorescently labeled 
dyes are attached to ACGT extension products in DNA sequencing reactions. 
The dyes come in four colors red (labels Thymidine base), blue (Cytosine), black 
(Guanine) and green (Adenine). The dyes are incorporated using either 5’-dye 
label primers or 3’-dye label dideoxynucleotide terminators. For each sample 
six separate sequencing reactions were performed using respectively the two 
inner PCR primers and four additional internal pol primers described in the 
Table 5. 
 
General protocol was as follows: 
 1µl each primer 5 µM working concentration 
 1µl of purified RT-PCR product, 
  2µl 5× Cycle sequencing dilution buffer 
 2µl BigDye 
 4µl ultrapure water.  
 
Final  reaction volume was  10μl 
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The sequencing PCR included 40 cycles of 96 ◦C for 30 s, 50 ◦C for 7 s and 
60◦C for 4 min. After running the sequencing reaction, non-incorporated 
dideoxynucleoside triphosphates were removed by 75% isopropyl alcohol 
precipitation and the pellet was resuspended in 20µl High Density Formamide 
(Applied Biosystems Incorporated, Foster City, CA) for denaturation and 
detected in an ABI Prism 310- Genetic Analyzer capillary electrophoresis 
system (Applied Biosystem, Foster City, CA, USA). Results were analyzed with 
the Sequencing analysis software v.5.2 (Applied Biosystem, Foster City, USA). 
3.8.  SEQUENCE DATASETSLLkkkkkkkkkkkkkkkkkkkLLLLLLLkkkkkkkk 
Analyses were performed on HIV sequences obtained from blood 
samples of 155 patients included in the study, collected from 2008 to 2013. 
Additionally, in this doctoral dissertation, 162 HIV-1 sequences from Serbia 
retrieved from the NCBI database, sampled in the period from 1997 to 2007, 
were also included. Accession numbers of the local sequences retrieved from 
NCBI database are listed in Table AI, Appendix 1. Furthermore, a total of 250 
HIV-1 sequences sampled worldwide and downloaded from the NCBI database 
(http://www.ncbi.nlm.nih.gov/nuccore), was also included in the 
phylogenetic analyses within this research. Criteria for inclusion of sequences 
were clearly identified subtype for each sequence, clearly established origin of 
each corresponding patient. Furthermore, for the tMRCA phylogenetic analyses 
clearly defined collection data of samples was also included, as an inclusion 
criteria. The country distribution and the accession numbers of all foreign 
sequences are listed in the Table AI shown in the Appendix 1. 
Within the scope of transmission clusters analyses, three viral sequences 
obtained from a man and two women, included in this study as previously 
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desribed, were phylogenetically analyzed for forensic investigation of 
suspected HIV-1 transmission case. In addition to viral sequences obtained 
from plasma samples, these three query viral sequences that were under 
forensic investigation were obtained from peripheral blood mononuclear cells 
(PBMC). From proviral DNA as starting template nested PCR was performed 
for both and pol and env gene. 
 For this purpose, 34 sequences of env gene region sampled from patients 
diagnosed in the time frame of two years preceding and two years after the 
time of diagnosis of the three query patients were also included in phylogenetic 
analysis as local controls. 
Furthermore, query sequences were used in the NCBI blast analysis 
(http://blast.ncbi.nlm.nih.gov) to search for the best-matching HIV-1 sequences 
according to score significance. The purpose was to identify additional highly 
similar sequences not included in the sampling. Ten sequences with the highest 
similarity scores to each query sequence were retrieved. To maximize the 
number of unrelated but high-scoring HIV-1 sequences from GenBank, those 
repeatedly selected were included only once, resulting in 30 GenBank 
sequences, from different geographical regions, as background controls.  
Intermixing of the best-matching HIV-1 foreign sequences downloaded using 
BLAST, with the ones under investigation would increase the probability of 
refuting the a priori hypothesis that case samples were involved in an alleged 
HIV-1 transmission chain. In view of possible epidemiological linkage to 
Thailand, 20 subtype B viral sequences in both pol and env, sampled from 
infected individuals in Thailand were included in the study, also retrieved 
through the BLAST search with query sequences using “Thailand” as an Entrez 
query to limit search. The final dataset analyzed consisted of 101 local and 50 
foreign sequences as controls for pol and 34 local and 50 foreign controls for env. 
Complete list of control sequences with countries of origin and NCBI accession 
numbers is found in the Table AII shown in the Appendix 2. 
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3.9. PHYLOGENETIC ANALYSES  KKKKKKkkkllllllllllllkkkkkkkkkkkkkkk
HIV sequences obtained during this study together with sequences 
downloaded from NCBI database were converted to appropriate format 
(FASTA, NEXUS) and analyzed using various phylogenetic software packages, 
depending on specific research questions. 
The multiple sequence alignment is the starting point for any 
phylogenetic analyses and it has to be done before a phylogenetic tree can be 
inferred. The accuracy of the alignment generated will directly affect the quality 
of any inference of phylogenetic history. The most frequently uses software, 
implementing the algorithm for multiple alignment is Clustal series of 
programs.  
Herein, Clustal W implemented in Molecular Evolutionary Genetics 
Analyses (MEGA version 6.0) software, was used for alignment of all nucleotide 
sequences obtained during the study (Tamura et al., 2011). It is phylogenetic 
based sequences alignment program that use progressive alignment methods. 
Firstly, a pairwise distance matrix for all the sequences to be aligned has to be 
generated, as well as „guided tree“ using the neighbor-joining algorithm 
(described in detail below). The guide tree serves as a rough template for clades 
that tend to share insertion and deletion features. Then, each of the most closely 
related pairs of sequences the outermost branches of the tree  is aligned to each 
other using dynamic programming.  
When editing the alignment, we kept the coding information for each 
sequence, using the HXB2 coding sequence for the same genomic region as a 
reference. Insertions relative to the HXB2 reference, as well as ambiguous and 
gapped regions, were removed from the alignment 
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Once an alignment has been constructed the relationship between the 
sequences can be derived from their evolutionary distances to each other. First, 
JmodelTest was used to carry out statistical selection of best-fit models of 
nucleotide substitution. This software implements five different model selection 
strategies: hierarchical and dynamical likelihood ratio tests (hLRT and dLRT), 
Akaike and Bayesian information criteria (AIC and BIC), and a decision theory 
method (DT). Herein, the best fitting nucleotide-substitution model was general 
time reversible model of nucleotide-substitution with a proportion of invariant 
sites (i) and gamma distribution of rates (C) (GTR + I + G), selected according to 
the Akaike Information Criterion (AIC) using all 88 proposed models. Once a 
model of nucleotide evolution has been selected it can be used in the inference 
of a tree with increased accuracy in relation to the genetic distances derived 
from the alignment. The evolutionary distances were computed using the 
Maximum Composite Likelihood method and are in the units of the number of 
base substitutions per site (Tamura et al., 2011). 
After an alignmnt has been generated, appropriate model of sequence 
evolution has been selected and evolutionary distances were computed a 
phylogenetic tree can be inferred. Phylogenetic tree building methods can 
broadly be classified as distance based and criterion-based or algorithmic.  
During the course of this research three different tree building methods, 
neighbor joining, maximum likelihood and Bayesian methods were used (Table 
6).  Neighbor joining is algorithmic distance matrix method that cluster taxa 
according to a pre-defined set of rules. Maximum likelihood and Bayesian 
methods are criterion-based methods search for the best tree according to some 
criterion. Algorithmic methods will return a single tree based upon a series of 
operations, whereas the search for an optimal tree in criterion-based methods 
means that multiple trees are considered and the ‘best’ tree is reported.  
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Table 6. Phylogenetic tree building methods. In bold are the ones that were 
used in this study 
 
 
TREE BUILDING 
METHOD 
DESCRIPTION 
DISTANCE-
BASED 
METHODS 
Unweighted Pair Group 
Method with Arithmetic 
Means (UPGMA) 
Phylogenetic tree is built based 
on pairwise distance matrix. 
Method assumes that the rate of 
evolution is linear 
Neighbour Joining (NJ) 
 Pairwise distances can be 
adjusted through application of 
appropriate evolutionary model 
and tree is constructed based on 
pairwise matrix 
CRITERION-
BASED 
METHODS 
Maximum likelihood 
(ML) 
Based on specific model of 
nucleotide substitution the 
method calculates the likelihood 
of all possible trees for the 
specified alignment, and selects 
the one associated with the 
maximum likelihood. 
Bayesian 
Evolutionary model is defined 
by user in order to calculate 
posterior probabilities of all 
possible trees for the specified 
alignment, and selects the one 
with the highest probability. 
Parsimony 
Tree constructed on the basis 
that the minimum number of 
evolutionary differences 
between sequences is the most 
likely. 
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In this thesis, the MEGA software was used to conduct distance-based 
(neighbor-joining) phylogenetic analyses, and PAUP software was used to 
construct ML trees. MrBayes and BEAST were used for Bayesian inference of 
phylogenies (Guindon et al., 2010; Tamura et al., 2011; Drummond and 
Rambaut , 2007; Ronquist and Huelsenbeck, 2003). Bootstrapped replicates of 
phylogenies were sampled to assess support for clades. The method of 
bootstrapping has been applied in phylogenetic analyto allow uncertainty in 
phylogenetic reconstructions to be assessed and it is perform in order to infer 
the reliability of branch order ses (Efron et al., 1996; Felsenstein, 1985). For an 
alignment of sequences where the rows represent different taxa and the 
columns are sites along the genome, columns of sites are randomly sampled 
with replacement to create a new alignment of the same size as the original. For 
the random sample a tree is then inferred. This resampling process is usually 
repeated many times (often 1000 times). The branch order on the correct tree is 
then compared to the random trees. In general the more random samples that 
support a given branch order on the tree the more reliable that branch order is. 
The minimum cut off for reliability is normally about 90%. Obtained 
phylogenetic tree were visualized and edited using the FigTree program 
version 1.3.1 (http://www.tree.bio.ed.ac.uk/software/figtree/) 
3.9.1. HIV SUBTYPINGLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL 
Obtained sequences were visually inspected, manually edited and then 
assembled with SeqScape HIV-1 Genotyping System Software v 2.5 (Applied 
Biosystem, Foster City, CA, USA). Firstly, analysis of viral sequences was 
performed using the REGA HIV-1 subtyping tool version 3 (REGAv3) 
(http://regatools.med.kuleuven.be/typing/v3/hiv/typingtool/) and the Los 
Alamos HIV database (https://www.hiv.lanl.gov/content/index). The Rega 
subtyping tool is based on phylogenetic analysis in order to take into account 
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the epidemiological and evolutionary relationships among subtypes (Robertson 
et al., 2000). 
Subtyping of all pol gene sequences collected during the course of this 
research was further performed by construction ML and NJ phylogenetic tree, 
under appropriate models, using the PAUP and MEGA software, with 
reference sequences of different subtypes, downloaded from HIV-1 Los Alamos 
Database (LANL, www.hiv.lanl.gov). Together with the pol sequences obtained 
in this research, subtype identification was also performed for 162 NCBI 
retrieved sequences dating from 1997-2007. Sequences that were not 
unambiguously classified by REGA subtyping tool or that were assigned to a 
different subtype from the one specified in the Los Alamos database were 
removed from the data set. 
 
3.9.2. PHYLOGENETIC ANALYSES OF TRANSMISSION 
CLUSTERKKKKKKKKKKKKKKKKKKKKKKKK 
The identification of transmission clusters, defined as viral lineages 
derived from the same variant, was accomplished through analysis of a series of 
criteria sets (Figure 11). In this part of research total of 304  pol gene sequences 
together with 250 background sequences were included. 
 Before starting this investigation, from all full codon alignment of 
sequences, 40 codons associated with major resistance in PR (30, 32, 46, 47, 48, 
50, 54, 58, 74, 76, 82, 83, 84, 88, 90) and RT (41, 62, 65, 67, 69, 70, 74, 75, 77, 100, 
101, 103, 106, 108, 115, 116, 151, 181, 184, 188, 190, 210, 215, 219 y 225) were 
removed (Johnson et al., 2013; Wensing et al., 2014). 
 According to the first set of criteria, transmission clusters were assigned 
as those phylogenetic clades consisting of three or more sequences, fulfilling the 
conditions of genetic distance of 1.5% or less, with minimal bootstrap support 
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of 90%. Additionaly, Bayesian inference were performed in MrBayes v3.1.2 with 
the GTR + G + I model of nucleotide substitution (Ronquist F, and Huelsenbeck 
J, 2003). In this analysis, two Monte Carlo Markov chains (MCMCs) are run 
simultaneously for the number of generations needed for a stationary 
distribution to be maintained long enough after convergence. Typically, the 
number of generations was 4 × 106 to 5 × 106, with the initial 10% of these 
generations discarded as burn-in.  Only those clades with statistical support of 
posterior probability higher 90% in the Bayesian analysis were considered as 
transmission cluster. 
Second criteria sets included those clades with bootstrap support over 
75% and with genetic distance of less than 4% were further analyzed. For every 
sequence belonging to such cluster, ten most similar sequences were identified 
using BLAST analysis. (http://blast.ncbi.nlm.nih.gov) and included in tree 
reconstruction as previously described. In the posterior analyses, only those 
clades with no intermixing of foreign sequences downloaded using BLAST, 
with the local ones, were considered as transmission clusters (Yebra et al., 2013).  
Lastly, the presence of transmission clusters was assessed using 
PhyloPart, a novel phylogeny based software for the identification of 
transmission clusters, under following parameters: threshold 0.05 and sample 
distance limit 4 (Prosperi et al., 2011). Only those clades which accomplish all 
conditions from the first or second set of criteria and were further con- firmed 
by PhyloPart were considered as transmission clusters and selected for further 
analysis. 
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Figure 11. Phylogenetic analyses and sets of criteria for identification of 
transmission clusters 
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3.9.3.  ESTIMATING TIME OF THE MOST RECENT COMMON 
ANCESTORLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL;;;;;;; 
Molecular clock analysis was performed using a Bayesian MCMC 
coalescent method, as implemented in BEAST v1.8.1 (Drummond et al., 2003; 
Drummond and Rambaut, 2007). We used GTR nucleotide substitution model 
with six category gamma distributed rate variation among sites and two 
partitions in the codon positions (the best fitting model for all three data sets 
according to jModelTest). As the different HIV-1 genes showed different rates 
of evolution. Preliminary analysis included combinations of two relaxed 
molecular clock models, ‘Relaxed: exponential’ and ‘Relaxed: log-normal’ in 
combination with four different coalescent tree priors: constant size, 
exponential growth, logistic growth and Bayesian skyline tree priors. Bayes 
factor analysis, performed in Tracer v.1.5,  showed that the lognormal relaxed 
clock with the Bayesian Skyline was the best model, as indicated by a log Bayes 
Factor >10 according to Tracer v1.5 (http://beast.bio.ed.ac.uk/Tracer) – 
evidence of very strong statistical support (Suchard et al., 2001). The Bayes 
Factor represents the ratio of the marginal likelihoods (approximated using the 
harmonic mean estimator) of the two models. Therefore in subsequent analyses 
we used uncorrelated log normal relaxed clock model and Bayesian skyline 
with 10 numbers of groups (Drummond and Rambaut, 2007). Rates were 
estimated taking into account the known sampling time of the sequences. A log-
normal prior was placed on the ucld.mean parameter (Hue et al., 2005; 
Zehender et al., 2010). A tree search was carried out running a Markov chain 
Monte Carlo (MCMC) sampler for 5 x 106 generations, sampling every 5000th 
generation. Convergence of the Markov chain was assessed by program Tracer 
v 1.5 (http://tree.bio.ed.ac.uk/software/tracer/) calculating the effective 
sample size (ESS) for each parameter. Tracer software analyses posterior 
samples of continuous parameters from Bayesian MCMCs to allow visual 
inspection of the chain behavior, estimating of the ESS of parameters and the 
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plotting of marginal posterior densities. Herein, ESS values higher than 100 
were considered robust. The ESS is the number of independent samples that 
would be the equivalent to the autocorrelated samples produced by the MCMC. 
This provides a measure of whether the chain has been run for an adequate 
length (for example, if the effective sample sizes of all continuous parameters 
are greater than 200).Tree samples were used to generate a maximum clade 
credibility tree (MCCT) after a 10% burn-in, using TreeAnnotator v 1.6.1 
(http://beast.bio.ed.ac.uk/TreeAnnotator). 
3.10. MOLECULAR FOOTPRINTS ANALYSES;llllkkkkkkkkkkkkkkkkllllll 
A bioinformatic approach was used to estimate the duration of infection 
by calculating the fraction of ambiguous nucleotides in the sequence as a 
delimiter for more recent (less than 1 year) versus chronic infection (longer than 
1year). Ambiguous mutations, representing a mixed nucleotide signal, were 
identified when the sequencing signal intensity of the minor base in both 
directions was ‡ 20% of the major base signal at a particular position. The 
method was applied using HIV sequences of newly diagnosed patients, to both 
the complete dataset and subtype B sequences only. In estimating duration of 
infection three different ambiguity cutoff values were evaluated (0.45%, 0.47%, 
and 0.5%) for recent infection. 
Amino acid (aa) substitutions at position 245 of HIV-1 reverse 
transcriptase (RT) have been described to be associated to the presence of 
human leukocyte antigen HLA–B*5701 allele in the host, in particular in 
subtype B infection. Therefore, this aa substitution can be used as a marker to 
identify individuals who may be safely treated with Abacavir. Furthermore, 
viral diversity in individual patients is reflected in the proportion of ambiguous 
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bases observed in HIV-1 pol sequences, including RT codon 245, obtained from 
population based genotyping with increasing diversity seen with increased 
duration of infection. 
3.11.  STATISTICAL ANALYSESjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj 
The results were analyzed by standard statistical analysis. Categorical 
data were compared using the chi-square test and Fisher’s exact test. To better 
understand the temporal trends of the epidemiology of HIV-1 infection in 
Serbia we analyzed trends in the major epidemiological parameters across two 
time periods: 1997-2007 (162 sequences existing in the GenBank database,) in 
comparison to 2008-2013 (sequences generated in this study,  isolated from 155 
patients).   
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4.1. STUDY POPULATIONKKKKKKKKKKKKKKKKKKKKLLLLLLLLLLL 
The majority of patients included in the research, were newly diagnosed 
62.5% (97/155), partly within the European project for monitoring of primary 
HIV resistance SPREAD/EuropeHIVResistence, while 37.5% (58/155) patients 
were on treatment. The overall population was 76% men, with over half of the 
total number of patients living in the urban areas and majority of patients 
reporting to be infected in Serbia. Information on transmission route was 
available for 139 patients, no risk factor was known for 16 patients. The majority 
of patients in the study were infected through sexual contact (97.4%). Regarding 
overall study population, MSM was the highest reported risk for infection in 
69.6% of all study patients (108/155), followed by heterosexual contact in 18% 
(28/155). Intravenous drug use was reported by a very small proportion of the 
population, 1.9% (3/155). Regarding transmission risk among patient in this 
research there was a significant difference in the prevalence of all STDs among 
MSMs compared to patients infected heterosexually (31% versus 11%, p = 
0.0287). 
 
General demographic and clinical data of the study population are 
shown in Table 7. 
  
 79  
 
 HIV-1 IN SERBIA 
Table 7. Basic demographic and epidemiological characteristic of the 
study population 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7. 
Characteristics of the study population 
Gender Patients 
Male 118 (76%) 
Female 37 (24%) 
Transmission route   
MSM 80 (51.6%) 
Heterosexual 55 (35.4%) 
IVDU 4 (2.5%) 
  16 (10.3%) 
Place of residence     
Urban area 132 (59.7%) 
Rural 66 (29.9%) 
Unknown 23 (10.4%) 
CDC disease stage     
A 60 (38.7%) 
B 25 (16.1%) 
C      35 (22.5%)   
Unknown       35 (22.5%)   
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The prevalence of transmission by men having sex with men (MSM) was 
much higher in the second half of the study period (39% in 1997–2007 compared 
to 77% in 2008–2013, p < 0.0001), whereas the prevalence of heterosexual 
transmission and the risk of transmission by intravenous drug use declined. 
The percentage of diagnosis in the earlier disease stage (CDC stage A) tended to 
increase in the second half of the study period and this increase was shown to 
be statistically significant (34% vs. 61%, p = 0.0012).The prevalence of sexually 
transmitted diseases (STDs), taking into account hepatitis B virus (HBV) as a 
sexually transmitted infection, was significantly increased in the second half of 
the study period (17%  vs. 38%, p < 0.001). 
 
General demographic, epidemiological and clinical characteristic of the 
patients included in this study compared to  data on 162 sequences retrieved 
from NCBI database are shown in Table 8. 
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Table 8. General demographic, epidemiological and clinical characteristic of the 
patients included in this study compared to data on 162 sequences retrieved 
from NCBI database, sampled in the period 1997 to 2007. Marked in red are 
characteristics with higher prevalence found in the second period (2008-2013, 
found to be statistically significant). Marked in blue are features with 
statistically higher prevalence found in the first period (1997-2007). 
 
Table 8. General epidemiological and clinical data of 
the overall population 
 
1997-2007 2008-2013 
 
  
 
NUMBER (percentage) OF PATIENTS 
 
162(51.1%) 155 (48.9%) 
 
GENDER 
Male 101 (62.3%) 118 (76.1%) 
Female 61 (37.6%) 37 (23.8%) 
  TRANSMISSION ROUTE 
MSM 45 (27.7%) 108 (69.6%) 
Heterosexual 69 (42.5%) 28 (18%) 
IVDU 17 (10.4%) 3 (1.9%) 
Transfusion 9 (5.5%) 0 
Unknown 22 (13.5%) 16 (7.6%) 
  MEDIAN AGE 
Male 35.19±11.07 33.19±8 
Female 34.19±9.7 30.1±8.7 
  PLACE OF RESIDENCE 
Urban 98 (60.4%) 112 (72.2%) 
Rural 64 (39.5%) 43 (27.8%) 
  CDC DISEASE STAGE 
A 42 (25.9%) 85 (54.8%) 
B 20 (12.2%) 25 (16.1%) 
C 72 (44.4%)                 35 (22.5%)   
Unknown  28 (17.2%)                10 (6.4%)   
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4.2. HIV SUBTYPINGJJJJJJJJJJKKKKKKKKKKKKKKKKKKKKKKKJJJJJJJJJ 
During the course this research, from 155 samples included in research, 
142 pol HIV sequences were successfully obtained, yielding full-length protease 
(PR) and more than 250 reverse transcriptase (RT) codons and 34 env HIV 
sequences, as well.  
The obtained sequences analyzed in this research were deposited in the 
GenBank database under the accession numbers: KF157435-KF157549, 
KX944763-KX944796. 
Rega subtyping tool and phylogenetic analysis, performed with Paup 
and MEGA software, of all 142 HIV-1 pol gene sequences obtained with a full 
length during the research gave congruent results in terms of subtype 
assignment.  
Results of this research showed that among HIV-1 infected patients in 
Serbia subtype B predominates 90.8% (129/142), while the prevalence of non B 
subtypes was 9.2% (13/142). Among non B subtypes, subtype C was found 
with the highest prevalence, in 3.4% (5/142) samples, followed by subtype A 
that was found in 2% (4/142). Circulating recombinant forms (CRFs) were 
detected in 2.8% (4/142) of the collected samples (Figure 12. and Table 8).   
In addition, results on prevalence of HIV-1 subtypes  obtained  in this 
research was compered to the one obtained from 1997 to 2007, in order to 
analyse statistically significant differences between to time period (Table 8.) 
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Figure 12. HIV-1 subtypes distribution from 2008-2013. 
 
 
Table 8. Changes in the distribution of subtypes in the two periods with similar 
viral sequences that were generated (1997-2007 vs 2008-2013). Statistically 
significant differences are marked in red  
 
 
PREVALENCE OF 
SUBTYPES  FROM  
1997 - 2007 
PREVALENCE OF 
SUBTYPES  FROM  
2008 - 2013 
SUBTYPE B 90.1% 90.8% 
SUBTYPE C 3.1% 3.5% 
SUBTYPE G 3.7% / 
SUBTYPE A / 2.1% 
CRFs 3.5% 2.8% 
SUBTYPE B
SUBTYPE C
SUBTYPE A
CRFs
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4.3. PHYLOGENETIC IDENTIFICATION OF TRANSMISSION CLUSTERS 
Phylogenetic analyses of transmission clusters included all 142 pol gene 
sequences of full length successfully obtained during the course of this research, 
162 pol viral sequences from local isolates obtained from 1997 to 2007 and a 
number of sequences from foreign isolates sampled worldwide, retrieved from 
NCBI database.  
Phylogenetic analysis of total 304 pol sequences revealed the presence of 
14 transmission clusters and 12 transmission pairs within the subtype B 
sequences (accounted for 275 sequences) included in the study (Figure 13). 
Considerable proportion, 57.4% (158/275) of local sequences were found 
intermixed in the phylogenetic tree with sequences sampled across Europe and 
North America, indicative of multiple subtype B introductions. However, 24.7% 
of analyzed subtype B sequences (68/275), were found grouped in 14 clusters 
that accomplished predefined sets of criteria (Figure 13., marked in dark blue). 
Eight clusters composed of 48 sequences in total were defined by the first, most 
stringent criteria set only, while 5 clusters were further added by second criteria 
set, including one well defined cluster, included in the forensic investigation. 
Furthermore, additional 17.5% (48/275) sequences were found to form a well-
supported separate phylogenetic clade (bootstrap support of 97%), albeit with 
the maximum pairwise genetic distance of 7.9% (range 0–7.9% SD 1.2 average 
2.3%) (Figure 13., marked in blue). The corresponding patients were diagnosed 
in a twelve year period (2002–2013) and the  majority of them were male 96%  
(46/48) and MSM 83% (40/48). Despite the high bootstrap value, maximal 
genetic distance of this clade exceeded the predefined ranges for transmission 
cluster, however, in view of the time-span of sampling within the clade and 
uniformity of transmission route, we considered it as a transmission network. 
Three of fourteen identified transmission clusters were part of this large 
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network. Thus, in total, 42.2% (116/275) of analyzed subtype B sequences may 
be considered to be part of transmission clusters/network.  
Transmission clusters ranged from 3 to 13 sequences with the mean 
number of patients per cluster 3.7, with collection dates within the span of 1–9 
years (mean 3.8, SD 2.2) and median pairwise genetic distance of 0.9% (range 0–
3.5%). Majority of clustering sequences were from patients living Belgrade 
66.1% (45/68), while 11/14 identified transmission clusters, containing 53 
sequences, were composed of viral sequences isolated from male patients 
(except for single sequence from a female patient) that predominantly reported 
MSM risk behavior (75.4%, 40/53). Remaining 3/14 transmission clusters 
included sequences from patients reporting heterosexual contact as risk for 
acquiring HIV infection, that were all living in Belgrade. Of note, these three 
heterosexual clusters contained significantly higher number of sequences 
isolated from women compared to predominantly MSM clusters (p< 0.001). We 
did not identify any transmission cluster encompassing sequences isolated from 
IDUs.  
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4.3.1.  FORENSIC APPLICATION OF PHYLOGENETIC ANALYSES 
HIV sequences of both pol and env genes were successfully obtained from 
all three query subjects, originating from both plasma RNA and PBMCs 
obtained DNA. A total of twelve sequences was deposited in the GenBank 
under the accession numbers: KF157495.1, KF157498.1, KF157497.1, KX944760, 
KX944761, KX944762, KX944797 - KX944802. 
The results of phylogenetic analysis of the two analyzed genomic regions 
(pol and env) were consistent, by all the applied methods. The three viral 
sequences isolated from patients whose epidemiologically linkage was under 
investigation were shown to form a well-supported separate transmission 
cluster that accomplished all predefined sets of criteria (Figure 14. a,  for pol 
and b for env gene). Phylogenetic tree showed no intermixing of local or foreign 
sequences into the transmission cluster. The cluster contained no viral 
sequences from Thailand. Phylogenetic analyses of HIV-1 pol and env sequences 
isolated from the three patients and a local population sample of HIV-1-positive 
individuals showed that sequences under investigation were more closely 
related to one another, than to any control sequences. The mean pairwise 
nucleotide divergence among three pol sequences included in the transmission 
cluster was 0.8% (0.3-1.1%), that is almost ten times less than mean pairwise 
nucleotide divergence among observed local controls pol sequences (7.1%). 
Regarding the env gene, known for its higher genetic variability, mean 
nucleotide divergence among three query sequences was 1.3% with maximum 
nucleotide divergence among them of 1.5% - in comparison to all observed local 
control sequences with mean nucleotide divergence of 16.1% and maximum 
nucleotide divergence of 26.3%. 
Each of the above described sequences from query samples was used as a 
starting point for EPLD-PCR analysis. A total of twelve sequences per patient 
per genetic region were generated and included in the phylogenetic analysis. 
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The end point limiting-dilution that resulted in positivity varied between the 
samples, from 81-fold to 243-fold. Phylogenetic trees based on the EPLD-PCR 
obtained viral sequences also contained the cluster specific for the three query 
patients with no intermixing of other viral sequences (Figure 15. and Figure 16). 
4.3.2.  PARAPHYLETIC RELATION BETWEEN QUERY SEQUENCES 
In this research, paraphyletic relationship between sequences of subjects 
2 and 3 and those of subject 1 was found, suggestive of the hypothesis of subject 
1 being the source of infection for both subjects 2 and 3. This finding would be 
in opposition of the a priori hypothesis of HIV transmission from subject 3 to 
subject 1, but would still correlate to the epidemiological a priori information. 
This relation was consistent when separately analyzing query subjects in pairs, 
as described previously (Romero-Severson et al., 2016). According to this 
approach, tree topologies of the EPLD-PCR based phylogenetic trees analyzing 
pairs of query subjects, revealed paraphyletic–monophyletic (PM) topology 
when sequences of Subject 1 were analyzed with either sequences of Subject 2 
and 3, in both env and pol genes (Figure 17 and Figure 18) . This result is 
consistent with the transmission scenario of Subject 1 being the source for both 
Subjects 2 and 3 (Romero-Severson et al., 2016). When analyzing sequences of 
Subjects 2 and 3, the obtained topology corresponded to dually monophyletic 
(MM) in the env region, implying the common source transmissions, whereas in 
the pol region the obtained topology corresponded to a combination of 
paraphyletic and polyphyletic (PP), which might be the consequence of a short 
time period between the two transmission events. 
 
 
 
 
 89  
 
 HIV-1 IN SERBIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. ML phylogenetic tree of  
a) pol gene sequences 
b) env gene sequences; under GTR+G+I substitution model 
obtained by MEGA software v. 6.0. Query sequences (from 
proviral DNA and RNA), 34 local control sequences together 
with background sequences (foreign sequences) obtained by 
BLAST were included. 
a) 
b) 
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Figure 15. ML phylogenetic tree obtained by MEGA software v 6.0 including 
EPLD query sequences of pol gene and local control pol gene sequences. 
 
 
SUBJECT 3  
SUBJECT 1  
SUBJECT 2   
LOCAL CONTROL 
SEQUENCES 
   2001    2003 2011 2007 2005 2009 2013 
   tMRCA Time (yrs) 
 91  
 
 HIV-1 IN SERBIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. ML phylogenetic tree obtained by MEGA software v 6.0 including 
EPLD query sequences of env gene and local control env gene sequences. 
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Figure 17. ML phylogenetic trees based on the EPLD-PCR obtained pol 
sequences of pairs of subjects: a) subject 1 and subject 2;  b) subject 1 and subject 
3; c) subject 2 and subject 3; together with local control seqences. Clusters of 
query subjects’ sequences are shown in color. 
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Figure 18. ML phylogenetic trees based on the EPLD-PCR obtained env 
sequences of pairs of subjects: a) subject 1 and subject 2; b) subject 1 and subject 
3; c) subject 2 and subject 3; together with local control seqences. Clusters of 
query subjects’ sequences are shown in color. 
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4.4.  TIMING THE ORIGIN OF THE MAIN CLADEPlllllllllllllllllllllllllllPPP 
The time of the Most Recent Common Ancestor (tMRCA) was estimated,  
using the Bayesian Markov chain Monte Carlo (MCMC) method implemented 
in BEAST v1.8.2., for all local subtype B sequences, for the transmission network 
of subtype B sequences and for the most extended transmission cluster, 
identified in the previously explained phylogenetic analysis (13 sequences) 
(Figure 19., Figure 21., respectively).  
The median tMRCA of the all local subtype B sequences was dated to 
1983 (95% HPD: 1977-1989) (Figure 19.). 
The tMRCA inferred for local transmission network composed of 48 viral 
sequences was in 1994 (95% Higher Posterior Density HPD: 1982–2000). 
Estimated temporal origin for the local subtype B transmission cluster, 
composed of 13 viral sequences, with bootstrap support of 100%,  was much 
more recent, 2004 (95% HPD: 2002–2006) (Figure 22.).  
Furthermore, temporal origin was also estimated for G clade and 
subtype C clade of Serbian sequences, as the most prevalent non B subtypes in 
the overall period (Figure 22., Figure 24., respectively). Considering estimated 
temporal origin of subtype G in Serbia it was found to be in the early nineties, 
1991 (95% Higher Posterior Density HPD: 1983–1999). For all local subtype C 
sequences, median tMRCA was found to be similar as for subtype G sequence 
with similar lower and upper credibility limits, 1990 (95% Higher Posterior 
Density HPD: 1984–1995). 
Bayesian skyline plots analyses showed an increase of subtype B 
sequences over the study period, contrary to the trend observed for subtype G 
and subtype C which showed limited dispersal over the study period (Figure 
20., Figure  22., and Figure 23., in comparison to Figure 25. and Figure 27.). 
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Figure 19. Time-scaled maximum clade credibility tree of all local subtype B pol 
sequences analyzed with BEAST, as obtained with tip dating. Branch lengths 
represent years before the last sampling time. 
1980 1985 1990 1995 2000 2005 2010 2015 
 
Time (yrs) 
 
tMRCA 
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Figure 20. Bayesian skyline plots representing the estimates of the effective 
number of subtype B sequences in the studied population. The y-axis measures 
the effective number of infections in log10 scale while the x-axis represents time 
in years with 0 (zero point) indicating year when the last sequence of subtype B 
was sampled (2013) followed with years indicated period in past. The line 
showing the median estimate of effective number of infections over time and 
blue coloured areas limiting the 95% HPD interval. 
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Figure 21.  Estimation of the tMRCA, obtained with BEAST v 1.4  using tip 
dating, of subtype B sequences within transmission network marked in blue 
(sub-clusters are marked in dark blue) , and the most extended transmission 
cluster (with 13 sequences), marked in  dark blue. Branch lengths represent 
years before last sampling time. 
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Figure 22. Bayesian skyline plots representing the estimates of the effective 
number of sequences within well defiened tranamission network in the studied 
population. The y-axis measures the effective number of infections in log10 
scale while the x-axis represents time in years with 0 (zero point) indicating 
year when the last sequence of subtype B was sampled (2013) followed with 
years indicated period in past. The line showing the median estimate of 
effective number of infections over time and blue coloured areas limiting the 
95% HPD interval. 
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Figure 23. Bayesian skyline plots representing the estimates of the effective 
number of 13 sequences within transmission cluster, supported by bootstrap of 
100%, in the studied population. The y-axis measures the effective number of 
infections in log10 scale while the x-axis represents time in years with 0 (zero 
point) indicating year when the last sequence of subtype B was sampled (2013) 
followed with years indicated period in past. The line showing the median 
estimate of effective number of infections over time and blue coloured areas 
limiting the 95% HPD interval. 
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Figure 24. Time scaled maximum clade credibility tree estimated using all 
Serbian subtype G sequences of pol region, analyzed with BEAST v1.8.1, as 
obtained with tip dating. The scale at the bottom of the tree represents the time 
in years before the last sampling time. 
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Figure 25. Bayesian skyline plots representing the estimates of the effective 
number of subtype G sequences in the studied population. The y-axis measures 
the effective number of infections in log10 scale while the x-axis represents time 
in years with 0 (zero point) indicating year when the last sequence of subtype G 
was sampled (2004) followed with years indicated period in past. The line 
showing the median estimate of effective number of infections over time and 
blue coloured areas limiting the 95% HPD interval.  
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Figure 26. Time scaled Bayesian MCMC tree estimated using all Serbian 
subtype C sequences of pol region, analyzed with BEAST v1.8.1, as obtained 
with tip dating. The scale at the bottom of the tree represents the time in years.   
  
Time (yrs) 
 
tMRCA 
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Figure 27. Bayesian skyline plots representing the estimates of the effective 
number of subtype C sequences in the studied population. The y-axis measures 
the effective number of infections in log10 scale while the x-axis represents time 
in years with 0 (zero point) indicating year when the last sequence of subtype C 
was sampled (2013) followed with years indicated period in past. The line 
showing the median estimate of effective number of infections over time and 
blue colored areas limiting the 95% HPD interval.  
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4.5. THE PREVALENCE OF MOLECULAR FOOTPRINTS ON HIV-1 
SEQUENCES ON AND THEIR ASSOCIATION WITH DURATON OF 
INFECTION; 
In this part of research, all pol viral sequences obtained only from therapy 
naive patients, included in this study were included. together with 110 
sequences sampled from 1997 to 2007, were analyzed. 
Based on the threshold of 0.47% ambiguous bases per sequence, a total of 
55.1% of samples (114/207) were classified as a recent infection, of duration of 
less than 1 year, whereas among subtype B samples this percentage was 54% 
(58/180). Lowering the threshold to 0.45% did not influence the result, nor did 
raising it to 0.5% (except in the subtype B dataset, where two additional 
samples were identified as recent infection with the least stringent cutoff of 
0.5%). In the first half of the study period (1997–2007) the percentage of recent 
infection was 35.4% (39/110) in the whole dataset and 36.6% (37/98) in subtype 
B samples only, while in the second part (2008–2013) this percentage was found 
to be 71% (69/97) and 70.9% (61/87), respectively. In both datasets analyzed 
(including non-B subtypes and subtype B samples only) this difference between 
the first and the second part of the study period was found to be statistically 
highly significant at an equal level ( p = 0.0003). Moreover, a comparison of the 
mean CD4 cell count between recently infected patients, based on a low 
percentage of sequence ambiguity, and those designated as patients with 
established infection, with the percentage of sequence ambiguity above the 
cutoff level, revealed a significantly higher CD4 cell count in the former group ( 
p = 0.0022).  
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 4.5.1.NUCLEOTIDE CHANGES AT 245 CODON OF HIV-1  RT 
GENE SEQUENCES 
The predominant aa at RT codon 245 was the wild type valine (V), found 
in 61% (168/275) , hence 36.7% (101/275) contained mutation at this position. 
The most common substitution at RT codon 245 was methionine (M) 22.9 
(63/275), followed by glutamic acid (E) 7,3% (20/275), glutamine (Q) 5.4% 
(15/275) and others. We found significantly higher prevalence of RT 245 
substitution, compared to the preliminary reports of the HLA-B*5701 allele 
frequency in HIV infected population in Serbia, p<0.0001. 
All transmission clusters associated sequences had wt aa at the position 
245. Contrary, 93.6% (44/48) sequences from transmission network had 
polymorphism at the investigated position. Based on the percentage of 
ambiguous basecalls, a total of 57% of naive samples (94/165) were classified as 
recent infection, while among these, 55.3% (52/94) had V at position 245. A total 
of 43% (71/165) were classified as chronic infection, with the presence of V at 
RT codon 245 found in 66.2% (47/71). We did not find significant association 
between polymorphisms at codon 245 and duration of infection (p=0.2107). 
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HIV is responsible for one of the largest viral pandemics in human 
history. Despite intensive efforts and considerable improvements that have 
been made for prevention and treatment, this pandemic still persists. In Serbia, 
the HIV/AIDS epidemic continues to expand, with over a hundred of new HIV 
diagnoses every year, lately affecting predominantly young MSM. 
Understanding the dynamics of HIV epidemic in Serbia, by utilizing novel 
methodologies, may result in major contribution to target public health 
measures to prevent future transmission events.  
The number of public health applications for molecular epidemiology 
and transmission network analysis has increased rapidly since the 
improvement in computational capacities and the development of new 
sequencing techniques (Vasylyeva et al., 2016). With the recent advances in 
nucleotide sequencing (i.e. high throughput sequencing technologies) which 
allow faster and more affordable sequencing of pathogens, vast amounts of 
genetic data can be produced faster, cheaper and more efficiently than ever 
(Grada and Weinbrecht, 2013). Due to global efforts in monitoring HΙV drug 
resistance, nowadays HIV is one of the most heavily sequenced human 
pathogen. 
So far, this study, including 162 Serbian viral sequences from 1997 to 
2007 together with sequences generated in this resaerch is the largest molecular 
epidemiologic investigation of HIV-1 epidemics in Serbia. This research 
encompassed investigation of current distribution of HIV-1 subtypes, changing 
epidemiology, transmission pathways, risk groups and way of dispersal, by 
means of phylogenetic analysis. Furthermore, herein we described the genetic 
diversity of HIV-1 strains circulating among infected patients in Serbia and 
investigated the level of intermixing of HIV-1 strains from Serbian isolates with 
those from other geographical areas. 
 Within the present study, we have obtained and analyzed 142 HIV-1 
sequences from different patients treated at the major HIV/AIDS health center 
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in Belgrade, Serbia, between 2008 and 2013. The demographics of the study 
population were comparable to the national HIV-1 epidemic, characterized 
predominantly by sexual transmission of infection (80%) and a high male-to-
female ratio (http://www.batut.org.rs/index.php?category_id=173; ECDC). In 
view of the size of the epidemic in Serbia, the size of the dataset and the time-
span in which these sequences were obtained provide enough confidence to 
consider the results obtained in this work as representative of the epidemic 
scenario of HIV-1 in this region. The results obtained from this research suggest 
that subtype B remains the predominant one, but with changes in distribution 
of non B subtypes over the years, the emergence of new non B subtypes and 
increased genetic diversity among them. The observed proportion of non-B 
clades was 9.1%, with the most common non-B subtype in Serbia that were 
found to be subtype C.  
The predominance of HIV-1 subtype B found in Serbia is concordant 
with reports derived from West and Central European countries. HIV-1 subtype 
B has been responsible for what is often called the ‘Western epidemic’ in 
Europe and has remained the predominant clade despite the introduction of 
non-B clades from later migrating populations, whilst in Eastern Europe the 
epidemic has been dominated by subtype A (Afsu) (Eastern-type epidemic) 
(Abecasis et al., 2013; Hemelaar et al., 2011). However, the complexity of the 
European HIV-1 epidemic has been increasing in Western and Central Europe 
during recent years, reflected in increasing prevalence of non-B subtypes, 
linked to migration and later dispersal through transmission networks with 
patterns varying between individual countries within the region (Beloukas et 
al., 2016). Population movements including migration from the African and 
Asian continents have changed HIV epidemic in European countries over the 
past two decades and have been linked to several infectious disease outbreaks, 
including local HIV-1 epidemics (Kentikelenis et al., 2015). Based on the fact 
that immigrants have mostly been infected with non-B strains, a valid 
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hypothesis is that they were infected, at least at some proportions, before 
migrating and therefore they could provide the main source of divergent strains 
in Europe (Beloukas et al., 2016). In Central Europe non-B clades are mainly 
linked with heterosexual route of transmission but not dominantly with non-
European origin. On the other hand, in the Eastern European sub-continent, 
non-B subtypes are  predominant and have been spread through a large PWID-
epidemic in FSU countries and in Russian Federation with heterosexual 
transmissions within local immigrants sexual networks. The SPREAD cohort 
database reveals B clade as predominant (70.2%) in newly HIV-1 diagnosed 
patients, after adjusting for oversampling in some countries, followed by C, 
CRF02_AG, G and A, with 5.0%, 4.9%, 4.8% and 3.6%, respectively (Beloukas et 
al., 2016). However, there are countries, such as Portugal, Cyprus, Sweden and 
Greece, where subtype B viruses are less prevalent in new infections ( ≤ 50%), 
whilst in the Czech Republic, Germany, Spain, Slovenia and Poland the 
prevalence of B clade exceeds 80%, with the highest prevalence of subtype B 
observed in Poland (96.2%) and Slovenia (93.6%) (Beloukas et al., 2016; 
Paraskevis et al., 2009; Abecasis et al., 2013). Non-B and CRF clades have mainly 
been associated with immigrants, heterosexual transmission and male gender. 
Distribution of HIV subtypes in countries neighboring Serbia is characterized 
by significant diversity, with high prevalence of non B subtypes in some of 
them (Stanojevic et al., 2012). In Greece among non-B genetic forms subtype A 
is the predominant one with very high prevalence and, furthermore, it 
circulates among the long-term residents in this country (Paraskevis et al., 
2007). Distribution of subtypes in Albania is marked by very high prevalence of 
subtype A, which is the predominant one, with the low prevalence of subtype B 
genetic form (Ciccozzi et al., 2005). Romania, which is the eastern neighbor of 
Serbia, is a unique case in Europe where HIV-1 epidemic started with subtype 
F1 which is still the most prevalent one (Abecasis et al., 2013; Paraschiv et al., 
2012). In Croatia subtype B predominates, albeit to a lesser extent compared to 
Serbia (Grgic et al., 2013). The most common non-B subtype in Serbia is found 
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to be subtype C, accounting for almost one third of all non-B infections. 
Worldwide, HIV-1 subtype C is currently the most prevalent subtype 
accounting for approximately 55% of all infections. Among the countries of 
WHO European region, subtype C is the most prevalent in Israel, where it 
accounts for 58% of all HIV infections. Here, non-B clades were introduced via 
two major routes; C clade viruses originated from Ethiopia and infected mainly 
heterosexuals and Afsu clade was introduced from FSU countries and 
circulated and expanded mostly among PWID transmission networks 
(Grossman et al., 2015). Subtype G, that was in Serbia, found to be the most 
prevalent one from 1997 to 2007, is the most prevalent one in Portugal (34.8%), 
where is well established in native population (Abecasis et al., 2013).  
Changes in the distribution of subtypes can be observed by comparing 
two periods with similar viral sequences that were generated (1997-2007 vs 
2008-2013). In two analyzed period subtype B was the predominate one with 
the prevalence of 90.1% and 90.8%, respectively for first and second period. 
However, difference was found among non B subtypes distribution. In period 
from 1997 to 2007 subtype G was found in almost half of the total number of 
non B sequences accounted for 6/162 (3.7%). In comparison, from 2008 to 2013 
none of 142 analyzed sequences was found to be of subtype G. On the other 
hand, prevalence of subtype C in the first period, that was found to be 5/162 
(3%) when compared to the second period, was the same. Furthermore, subtype 
A sequences were only identified in the period from 2008-2013 while none of 
sequences from first period were identified as subtype A. In contrast only in the 
first period one patient was identified to carry subtype F virus, while this 
subtype was not identified in the second one.  
Results of this research highlighted the benefits of using detailed 
molecular epidemiological methods for studying epidemics. Monitoring the 
prevalence of different clades is useful and can provide information about the 
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genetic diversity of circulating strains as well clues about the potential origin of 
infections.  
Our findings reflect some particular aspects of the HIV-1 subtype 
distribution in Serbia. The proportion of MSM was significantly higher in 
subtype B infected patients than in those infected with other subtypes. 
Regarding subtype B epidemics, our findings are suggestive of multiple 
subtype B introductions in Serbia.  A previous phylogeographic study has 
shown important level of ‘‘mixing’’ of HIV-1 subtype B sequences across 
Europe, where sequences from Serbia were found highly interconnected to 
those from other European countries (Paraskevis et al., 2009). However, a 
number of subtype B introductions have resulted in further local dispersal, 
giving rise to local transmission chains. The majority of patients carrying non B 
subtype strains were infected through heterosexual contact and this association 
was found to be statistically significant. Numerous studies have shown that 
non-B infections in Europe are mainly associated with heterosexual infection 
among immigrants or persons epidemiologically linked to sub-Saharan Africa 
(Thomson and Nájera, 2001). In contrast to that finding, the vast majority of 
patients in this study reported to be infected locally, with no epidemiological 
links abroad. The recent study based on HIV isolates of newly diagnosed 
patients throughout Europe has shown that transmission risk for HIV is among 
the main determinants of subtype distribution (Abecasis et al., 2013). Contrary 
to the majority of western countries where subtype B epidemic was firstly 
described in the MSM population and subsequently found associated with 
other transmission routes, in particular PWID, epidemiological data indicate 
that the epidemic of HIV in Serbia was first established in PWID and was 
almost exclusively caused by the subtype B genetic form, (Stanojevic et al., 
2002). In this respect,  the HIV epidemic in Serbia is similar to the one in Italy, 
where the most common route of transmission, at the beginning of the 
epidemics, was also found to be needle sharing among intravenous drug users 
(Callegaro et al., 2011).  
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In Serbia, as in other countries, the HIV epidemic is evolving with 
changing patterns of the HIV subtypes present and prevailing transmission 
risk. In this research, the changing epidemiology of HIV-1 disease among main 
transmission groups was described. HIV epidemic in Serbia has entered a new 
phase with the number of infections acquired through MSM contact, rising each 
year. Our findings are in line with epidemiological data indicating that, unlike 
previously found, MSM contact currently represents the driving force of the 
HIV epidemic in Serbia, followed by heterosexual contact, while infections 
among injecting drug users are at low levels.  
The remarkable finding of this study was identification and 
characterization of HIV-1 transmission clusters in Serbia by analyzing large 
scale of 304 sequences from isolates sampled between 1997 and 2013, that were 
for the first time described in this research. This study demonstrates a unique 
view into the structure of local transmission in Serbia through the integration of 
molecular, clinical, and demographic data. Molecular epidemiologic evaluation 
of HIV-1 transmission networks can elucidate behavioral components of 
transmission that can be targets for intervention Understanding HIV 
transmission patterns is important in the design and implementation of 
prevention interventions. One of the major challenges in transmission clusters 
analysis is adoption of adequate phylogenetic criteria for cluster identification. 
There is no consensus on phylogenetic criteria that should be used to 
established a putative transmission cluster in phylogenetic based studies of HIV 
transmission network. Those are generally based on defined cut-off bootstrap 
support and/or genetic distance values, but also include Bayesian probability 
and reference sequence analysis. Appropriate phylogenetic criteria may depend 
on the underlying epidemiological and evolutionary dynamics in a given 
research settings. 
Notably, this study highlighted the need for consensus criteria on 
defining transmission clusters, by showing that using strict criteria for 
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clustering (high bootstrap values and low genetic distances) can result in 
underestimation of number of true transmission clusters. Using a tight 
definition for transmission clustering in which inclusion in a cluster required 
each sequence to have another sequence within a genetic distance of ≤ 1.5% can 
likely select viral sequences isolated only from patients with early HIV 
infection. Instead of using only this strict criteria, applied up to now in several 
research , herein we used an additional and more stringent criteria in order not 
to exclude from actual clusters sequences from related chronically infected 
patients. Criteria sets used in our analysis were aimed to be sufficiently strict, in 
order to maintain specificity in identifying true transmission clusters, yet to 
avoid underestimation of the incidence of transmission chains, in particular in 
view of the rather extended ten years timeframe of sampling. On the other 
hand, the range of identified transmission events and the level of their 
epidemiological linkage are largely influenced by sampling strategy and the 
level of coverage of target population. Our sample corresponds to around 10% 
of the total number of registered cases from the beginning of the epidemics, 
however, it contains around 30% of all newly diagnosed patients in the years of 
the study period. The proportion of patients involved into clustered events in 
our study, of 24.5% within characterized transmission clusters and 16.7% within 
larger transmission network, is in the range of 12.7% to 64% as found in reports 
from others geographical regions, although both the populations and the 
methods of these phylogenetic studies are heterogeneous (Brenner et al., 2007, 
2011; Chalmet et al., 2010; Frange et al., 2012; Hué et al., 2005; Recordon-Pinson 
et al., 2009; Yerly et al., 2009). Transmission clusters identified in our study are 
highly associated with male, in particular MSM patients, rather than with 
people infected heterosexually or IDU. Compared to other studies we found 
that local transmission structure in Serbia is similar to the regions where MSM 
transmission predominates. Depending on the studied population, some 
studies revealed transmission structure of equal contribution to HIV epidemic 
through HIV spread among both heterosexual and MSM risk groups (Dennis et 
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al., 2012). However, increase in the proportion of HIV-1 transmission through 
MSM networks has been reported in a number of studies throughout the world 
(Cuevas et al., 2009; Kouyos et al., 2010; Lewis et al., 2008; Mitsch et al., 2008; 
Paraschiv et al., 2012). The latest molecular epidemiological data show that 
clustering of HIV infections in high-transmission bursts and faster spread in 
networks are associated with HIV epidemics in MSM, much more than related 
to heterosexual transmission (Beyrer et al., 2012a). Substantial clustering of HIV 
infections in MSM networks underscores the need of reinforcing prevention 
measures within this group on the local level (Beyrer et al., 2012b). This notion 
is further emphasized by the analyses of the temporal origin of subtype B 
epidemics in Serbia. Higher rates of clustering in MSM, suggest that public 
health interventions should target this key population at risk, including 
prevention, testing and linkage to care strategies, to reduce HIV-1 transmission 
in Serbia. 
In comparison to human DNA, genome of RNA viruses is much less 
stable, undergoing dynamic evolution (Rambaut et al., 2004). Expansion of 
multiple viral lineages in infected individual is driven by high rates of 
mutation, large population sizes and short generation times. Hence, unlike 
common practice of DNA fingerprinting, analyzing the transmission of fast 
evolving viruses such as HIV is difficult since finding full identity between two 
HIV samples is highly improbable (Abecasis et al., 2011).  Nevertheless, virus 
sequences sampled from epidemiologically linked individuals are likely to be 
more closely related compared to unlinked ones. This phenomenon can be 
exploited to give forensic evidence whether or not there is a genetic relatedness 
between viral sequences from alleged donor and an infected individual (de 
Oliveira et al., 2006; Saludes et al., 2013; Scaduto et al., 2012; Metyker et al., 
2002; González-Candelas et al., 2003; González-Candelas et al., 2013) 
In Serbia, as in many countries worldwide, deliberate exposure to and 
transmission of HIV are criminalized (Weait, 2011). In this study, initiated by 
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the investigative process within the private lawsuit regarding HIV 
transmission, partial polymerase (pol) and envelope (env) genetic segments 
were analyzed in order to infer genetic relatedness and explore suspected 
epidemiological linkage between HIV genome sequences isolated from three 
HIV-1 infected patients. 
Phylogenetic analysis of transmission clusters as a forensic evidence in 
criminal HIV transmission prosecutions were first used in court of low in 
Sweden in 1992 (Albert et al., 1994). In order to give strong forensic evidence 
regarding transmission, phylogenetic analysis needs to be enhanced with 
application of several methods and conducted under strictly controlled 
conditions (Bernard et al., 2007; Leitner and Albert, 2000). Firstly, it is vitally 
important to include adequate local controls comprising viral sequences from 
infected individuals sharing the same transmission risk, from similar 
geographic location, of the same genetic clades (subtype or recombinant form), 
and diagnosed in the same time period as the query subjects, but who are not 
believed to be a part of the investigated outbreak. The use of inappropriate 
controls could overemphasize the relatedness between the viruses under study 
as being uncommonly unique (Leitner and Albert, 2000). All infected 
individuals in a population can never be sampled, nevertheless, if sufficient 
number of local control sequences is included in the analyses, significant 
clustering of sequences under investigation can indicate that they do belong to 
a transmission chain. Secondly, apart from appropriate local controls, 
additional precondition in forensic phylogenetics is inclusion into the analysis 
of at least two genetic regions of reasonable length, depending on the gene 
under investigation. To our best knowledge, this is the first report of 
phylogenetic analyses utilized for forensic exploration of suspected HIV 
transmission in Serbia. The current Criminal Code of Republic of Serbia 
recognizes deliberate or inadvertent spread of HIV, and it is punishable by 1–15 
years sentence (http://www. paragraf.rs/propisi/krivicni_zakonik.htm, in 
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Serbian). In this study, phylogenetic analyses indicated that the three HIV 
sequences under investigation were all of subtype B and more genetically 
related to each other than to any control sequence. Notably, pairwise 
dissimilarity between the 3 query sequences was much lower than average 
between controls. However, due to an unknown number of unsampled HIV 
infected individuals from the same transmission network, accurate transmission 
history cannot be unambiguously reconstructed. Further, restricting genetic 
distance indicative of transmission cluster to a threshold of 1.5% across the 
studied genome part has not been universally accepted, since transmission 
events may have been separated in time, allowing further evolution. Hence, the 
level of similarity and phylogenetic clustering of the examined sequences does 
support their epidemiological relatedness, however cannot be considered proof 
of their direct epidemiological linkage. Moreover phylogenetic analysis cannot 
be used to unambiguously infer the directionality of transmissions (who 
infected whom). An approach to address this issue is based on the topology of 
the phylogenetic tree, if a paraphyletic relationship is observed (i.e., a subset of 
source viral sequences is more closely related to all recipient sequences than to 
other source sequences) (Scaduto et al., 2010). This assumption is based on the 
fact that HIV-1 infection is associated with a transmission bottleneck: newly 
acquired HIV infection (in particular when sexually transmitted) is established 
by a limited number or a single viral strain (Keele et al., 2007). In this research, 
paraphyletic relationship between sequences of subjects 2 and 3 and those of 
subject 1 is found, suggestive of the hypothesis of subject 1 being the source of 
infection for both subjects 2 and 3. This finding would be in opposition of the a 
priori hypothesis of HIV transmission from subject 3 to subject 1, but would still 
correlate to the epidemiological a priori information. This relation was 
consistent when separately analyzing query subjects in pairs, as described by 
Romero-Severson et al. (Romero-Severson et al., 2016). According to the 
analysis approach by Romero-Severson et al. (Romero-Severson et al., 2016), 
tree topologies of the EPLD-PCR based phylogenetic trees analyzing pairs of 
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query subjects, revealed paraphyletic–monophyletic (PM) topology when 
sequences of Subject 1 were analyzed with either sequences of Subject 2 and 3, 
in both env and pol genes . This result is consistent with the transmission 
scenario of Subject 1 being the source for both Subjects 2 and 3 (Romero-
Severson et al., 2016). When analyzing sequences of Subjects 2 and 3, the 
obtained topology corresponded to dually monophyletic (MM) in the env 
region, implying the common source transmissions, whereas in the pol region 
the obtained topology corresponded to a combination of paraphyletic and 
polyphyletic (PP), which might be the consequence of a short time period 
between the two transmission events. Still, caution is needed with regards 
potential interpretation of findings in a forensic case in court. Even with 
phylogenetic analysis performed using state of the art phylogenetic methods 
together with the strictest conditions for cluster identifications, indirect link 
between viral strains can never be ruled out; hence even demonstrating 
direction of transmission is not identical to demonstrating direct transmission 
from one to another (Abecasis et al., 2011). Furthermore, at the molecular level 
sequences also contain temporal information about the date of origin and age of 
epidemics. Therefore, using Bayesian Markov chain Monte Carlo (MCMC) 
approach we can estimate the date of the most recent common ancestor of each 
cluster, even including clusters formed from viral variants of one infected 
person. Neither of these methods should be used separately but together with 
other epidemiological, clinical and behavioral data as well as with other 
forensic evidence and only in the context of hypothesis testing. The dated tree 
in our analysis confirmed the clustering pattern of query sequences. Obtained 
tMRCA estimates for the time of infection for subject 1 preceded the estimates 
for the time of infection for subjects 2 and 3, consistent with the dates of 
diagnosis and also suggestive of the hypothesis of subject 1 being the source of 
infection for both subjects 2 and 3, opposite to the a priori hypothesis. Besides 
the limitations inherent to phylogenetic analyses of HIV transmission, our 
study has some additional limitations. We had access only one sample per 
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subject, whereas it is preferable to have two, from different time points. It is 
recommended by the relevant guides to analyze preferably two or more 
samples of the same subject (Bernard et al., 2007). However, as stated under the 
limitations of the study, we had access to only single sample per subject. In this 
research, follow-up sampling was not possible, the main reason being the fact 
that all the subjects meanwhile started the successful antiretroviral therapy 
leading to undetectable viral load in further samples. However, using an EPLD-
PCR approach to assess viral quasispecies allowed to sufficiently explore viral 
diversity at the given time point. Further on, the identities of the parties were 
not blinded to us throughout the analysis. However, the analysis was 
performed in compliance to all other recommendations for forensic application 
of phylogenetic analysis, whereas, circumstantially, the case has been settled 
out of court 
The availability of greater numbers of sampled viral sequences combined 
with increasing power of phylogenic techniques makes it possible to retrieve 
valuable and unique information about the course of viral epidemics from 
molecular data (Lemey et al., 2003; Robbins et al., 2003; Travers et al., 2004; 
Deng et al., 2008).  
Many studies were based on partial pol gene phylogeny, which has 
shown to be adequate to infer transmission events and to characterize 
epidemiological patterns of public health relevance (Hué et al., 2004; Lemey et 
al., 2005). The pol region of the HIV genome is generally used for phylogenetic 
analyses out of convenience, since it is a by-product of the routine HIV drug 
resistance testing. Lemey et al., showed that pol gen, analysed also in this 
research to infer transmission events, is adequate and very good region for 
reconstructing transmission chains and characterisation epidemiological 
patterns of public health relevance (Lemey et al., 2005).  However, there are 
concerns that the pol region is too conserved since it codes for regulatory genes 
involved in viral replication and consequently has insufficient genetic 
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variability (Palmer et al. 2002). This has led to debate about its suitability for 
phylogenetic reconstructions (Palmer et al. 2002; Sturmer, Preiser et al. 2004). 
While gag and env genes have been preferred due to their greater genetic 
variability, pol remains attractive due to its greater accessibility through routine 
drug resistance testing. Hue et al (Hue et al. 2004) 
Studies of the evolutionary history of HIV enable us to explore the past 
and to estimate the age of an epidemic. Phylogenetic analysis has successfully 
been used to investigate HIV-1 transmission and epidemiological linkage, 
however, the direction and timing of HIV-1 transmission are far more difficult 
to assess (Rachinger et al., 2011). Standard phylogenetic reconstruction only 
establishes evolutionary relatedness but not evolutionary direction. The 
integration of molecular clock models in phylogenetic inference has enabled the 
reconstruction of rooted, time-measured phylogenies (Drummond et al., 2002; 
Rachinger et al., 2011). 
In this doctoral dissertation phylogenetic analyses and a Bayesian 
coalescent-based framework was used,  to investigate the origin and to estimate 
with more precision the initial introduction of the HIV-1 subtype B in Serbia. 
We based this analysis on datasets of pol gene sequences sampled over a period 
of 17 years (1997-2013). Molecular clock analysis dated the initial introduction 
of  both the founder strain of IDUs and MSM in a similar period to the early 
1980s. Our findings suggest that IDU populations might have played a major 
role in the introduction and initial dissemination HIV-1 in Serbia. In contrast to 
IDU regional spread among MSM population that gave rise to local 
transmission chains happened years after initial introduction of founder strain. 
Molecular clock analysis dated the tMRCA of the large network of Serbian 
subtype B sequences to 1994 (95% Higher Posterior Density HPD: 1982–2000), 
whilst for the most extended local subtype B MSM transmission cluster tMRCA 
was estimated at 2004 (95% HPD: 2002–2006)  
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Estimated origin of the subtype C epidemics in Serbia is much more 
recent, however, similar to the time found for subtype G in the previous study  
By reconstructing the evolutionary history of viral genomes the behavior 
of viral populations can be modelled, and the future of epidemics may be 
forecast. Together with epidemiological data these findings illustrate that the 
epidemic spread of HIV in Serbia within the local network and outside the 
firstly implicated IDUs community probably started in the beginning of 90s, 
while epidemic spread of HIV subtype B among MSMs represents the most 
recent HIV-1 epidemic in Serbia. Evolutionary studies based on a single gene 
analysis may suffer from limitations of evolutionary rate varying between 
genes due to numerous host and virus related factors, giving rise to either 
overestimation or underestimation of the timeframe of viral introduction 
(Abecasis et al., 2009; Neogi et al., 2012). However, many newly reported 
studies, pol gene based or comparing tree genetic regions (gag, pol, env), have 
shown pol-gene analysis to provide the most reliable estimate of tMRCA 
(Ciccozzi et al., 2012; Han et al., 2013; Neogi et al., 2012; Paraschiv et al., 2012; 
Yebra et al., 2013). We estimated the origin of the subtype G epidemics in Serbia 
to the beginning of the 90s, however the subsequent dispersal within the local 
population remained limited. Decline in the prevalence of heterosexual HIV 
transmission in recent years as well as proven relationship between this risk 
group and non B subtypes may be the reason for the absence of further spread 
of the subtype G epidemic in Serbia.  
HIV-1 infection is associated with a transmission bottleneck: newly 
acquired HIV infection (in particular when sexually transmitted – which is the 
case in almost 90% of our study population) is established by a limited number 
or a single viral strain (Keele et al., 2008). Further intrapatient viral evolution 
over time leads to increasing HIV viral diversity within individuals by initial 
accumulation of mixed bases, as new mutations emerge in existing 
quasispecies. Hence, a threshold of percentage of ambiguous bases per 
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sequence has been proposed to identify non-recent vs. recent HIV infection (the 
one lasting less than 6 months to 1 year). Essential for this method’s 
performance is standardized mixed bases calling, variability whereupon lays 
ground for intrasample and intersample interpretation variability, using either 
automated or manual sequence editing. However, it has been shown that 
duration of HIV infection can be inferred from the proportion of mixed bases 
identified during population-based sequencing of the pol region, with similar 
accuracy using any mixed base threshold between 15% and 25%. The threshold 
we used falls within the proposed range. Furthermore, a cut-off of 0.47% of 
ambiguous nucleotides for distinguishing recent from established infection has 
been proposed for HIV subtype B pol gene sequences, whereas differing 
percentage has been described for some of the non-B subtypes (Zheng et al., 
2013). We found high prevalence of HLA B*57 associated polymorphism that is 
almost twice as reported prevalence of HLA B*57-01 allele in Serbia (8%). This 
may be related to the presence of other, similar HLA alleles, limiting specificity 
of the correlation between HLA-B*5701 and RT codon 245 variation. 
Furthermore, our well-supported separate phylogenetic network was consisted 
of 51% (25/54) sequences with HLA B*57 associated polymorphism. In 
addition, no statistically significant difference was found in the prevalence of 
RT 245 substitutions between recent and chronic infection. In view of the time-
span of sampling within the clade and uniformity of transmission route (mainly 
MSM) this may be related to early fixation of an HLA induced selective imprint, 
during viral evolution in an infected drug naive patient and its onward spread. 
On the other hand, these results may imply that mutation at RT codon 245 in 
patients infected with HIV strain caring mutation on this position tend to 
reverse into a wild type form during the evolution of a virus in infected 
individual in order to incise adaptive value (W) and higher fitness effect of the 
virus. 
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According to the defined objectives and based on the obtained results the 
following conclusions can be reached: 
 
 HIV epidemics in Serbia continues to be dominated with subtype B, but 
with changes in distribution of non B subtypes over time, the emergence 
of new non B subtypes and increased genetic diversity among them. 
 
 
 The majority of patients carrying non B subtype strains were infected 
through heterosexual contact and this association was found to be 
statistically significant. 
 
 
 An important proportion of the local subtype B spread is slustered, with 
39.6% of analyzed sequences may be considered to be part of 
transmission clusters/network. 
 
 
 Transmission clusters are highly associated with MSM rather than with 
other risk categories. 
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 Transmission cluster analysis in the context of forensic investigation 
revealed a well-supported transmission chain, in line of the a priori 
hypothesis of their epidemiological linkage with tree topology possibly 
implying the direction of transmission contrary to the a priori hypothesis. 
It is important to emphasize that the results of forensic phylogenetics 
need to be interpreted in the context of hypothesis testing and in view of 
all the limitations of this approach. 
 
 
 tMRCA for local HIV epidemic in Serbia, regardless of the transmission 
risk, dates back to the early eighties of the 20st century. 
 
 
 Local epidemic spread within transmission networks and outside the 
firstly implicated IDUs community is dating from the beginning of the 
nineties, while epidemic spread of HIV subtype B among MSMs 
represents the most recent HIV-1 epidemic in Serbia. 
 
 
 Non-B epidemics in Serbia, although introduced at a similar time (early 
90s), resulted in limited dispersal, and exemplified by subtype G clade, 
possibly due to the prevailing transmission route. 
 
 
 Ambiguous nucleotides analyses, used as a method for distinguishing 
recent from established infection suggested an increasing proportion of 
recent infections, significantly higher in the second half of the study 
period. 
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 Equal prevalence of RT 245 substitutions in samples from recent and 
chronic HIV infection, together with high prevalence of this 
polymorphism in sequence within transmission network, suggested 
early fixation of an HLA induced selective imprint, during intra-host 
viral evolution and  raises the question of onward transmission of HLA 
induced mutation and their inter-host persistence. 
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KKKKKKKKLIST OF ABBREVIATIONS AND ACRONYMSKKKKKKK 
 
AIDS 
 
Acquired Immunodeficiency Syndrome 
 
Afsu Subtype A Former Soviet Union 
aa 
 
Amino Acid 
 
BLAST Basic Local Alignment Search Tool 
 
CDC 
 
Centers for Disease Control and Prevention 
 
CD4 
 
 
Cluster of Differentiation 4 
CCR5 
 
C-C chemokine receptor type 5 
CXCR4 
 
C-X-C chemokine receptor type 4 
CRF Circulating Recombinant Forms 
 
DNA 
 
 
Deoxyribonucleic Acid 
DRC Democratic Republic of Congo 
 
dNTP 
 
 
deoxyribonucleotide triphosphate 
env 
 
Envelope 
EPLD End Point Limited Dilution 
 
FASTA 
 
text-based format for representing nucleotide sequences 
gag group specific antigen gene 
 
gp 
 
glycoprotein 
 
GRID 
 
Gay Related Immune Deficiency 
 
GTR 
 
Generalised time reversible model 
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GTR+G+I 
 
GTR plus gamma (Ƚ) and proportion invariant model 
 
HAART 
 
 
Highly Active Antiretroviral Therapy 
HHV-8 Human Herpesvirus 8 
 
HIV 
Human Immunodeficiency Virus 
 
HIV-1 
 
Human Immunodeficiency Virus type 1 
 
HIV-2 
 
Human Immunodeficiency Virus type 2 
 
HIVdb 
 
Stanford HIV Drug Resistance Database 
 
HLA 
 
Human Leukocyte Antigen 
HPD 
 
Highest posterior density 
HTLV-III 
 
Human T-Lymphocyte Virus III 
IN Integrase 
LAS Lymphadenopathy Syndrome 
LAV Lymphadenopathy-Associated Virus 
LANL 
 
Los Alamos National Laboratories 
LTR Long Terminal Repeats 
MCMC Markov Chain Monte Carlo 
 
ML 
 
Maximum Likelihood 
 
MTCT 
 
Mother to Child Transmission 
 
MSM 
 
Men who have Sex with Men 
NCBI 
 
National Center for Biotechnology Information 
 
PBMC Peripheral Blood Mononuclear Cells 
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PCR Polymerase chain reaction 
 
PIs 
 
Protease Inhibitors 
pol Polymerase gene 
 
PR 
 
Protease 
 
PWID People Who Inject Drugs 
 
REGAv3 
 
REGA automated subtyping tool version 3 
 
RNA 
 
Ribonucleic Acid 
 
RT 
 
Reverse Transcriptase 
SIV 
 
Simian Immunodeficiency Virus 
STI 
 
Sexually Transmitted Infection 
 
 
tMRCA 
 
time to Most Recent Common Ancestor 
 
UNAIDS 
 
Joint United Nations Programme on HIV/AIDS 
 
WHO 
 
World Health Organisation 
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APPENDIX 1. Table AI. Accession numbers and country of origins of pol gene 
sequences from Serbian isolates sampled from 1997 to 2007 and foreign isolates 
obtained by NCBI database. 
 
POL GENE 
ACCESSION NUMBER 
COUNTRY 
OF ORIGIN 
AY433800; AY433798; AY433797; AY433796; AY433795; 
AY433794; AY433793; AY433792; GQ399763; GQ399551; 
GQ400327; GQ400482, GQ398972; GQ399179; GQ399012; 
GQ399888; GQ399221; GQ399018;  GQ480327; GQ399263; 
GQ395533; GQ400459; GQ400490; GQ400092; GQ399955; 
GQ400505; GQ39934; GQ399810; GQ398855; GQ400529; 
GQ400303; GQ400203; GQ400169; GQ399328; GQ398698; 
GQ399770; GQ399505; GQ399605; GQ399463; GQ399262; 
GQ400380; GQ399684; GQ399526; GQ400192; GQ399335; 
GQ400562; GQ400664; GQ400943; GQ400568; GQ400867; 
GQ399293; GQ400985; GQ400636; GQ400934; GQ400637; 
GQ400971; GQ400727; GQ400860; GQ400842; GQ400711; 
GQ400847; GQ400975; GQ401005; GQ400863; GQ399151; 
GQ400634; GQ400696; GQ400623; GQ400576; GQ400698; 
GQ400683; JX299860; JX300595; JX300466; JX301157; JX300670; 
JX300934; JX300963; JX301026; JX299883; JX299967; JX300342; 
JX300698; JX301113; JX299941; JX300732; KF157408- KF157434 
Serbia 
AY611666; AY611672; AY611684; AY611688 Albania 
AF347214; AF347518; DQ878531; DQ878532 Austria 
DQ177230; DQ177232; DQ877759; FJ653084; EU248460 
DQ177224; DQ177231; DQ177227;  DQ177234.1; 
DQ177218.1;  KF301720.; DQ177231.1 
 
Belgium 
EF517439; EF517457; EF517462; EF517464; EF517488; EF517472; 
EF517439; EF517410 
Bulgaria 
FN424300; FN424301 Croatia 
EU673375; EU673382; EU673408 Cyprus 
AY694218; AY694233; AY694364 
Czech 
Republic 
AJ419453; AJ582147; AM490879; DQ108366; DQ87779 Denmark 
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AF487122; DQ878075; DQ877953; DQ877930 France 
AF347190; AF347288; AF347140; AY878668; AY878677; 
DQ878276; DQ878304 ; FJ030769; GQ400800;  KC340462.1; 
KX467180.1; KX467175.1; KX467167.1; KX467170.1; KX467149.1 
Germany 
DQ878544; DQ878548; DQ878559; DQ878569; DQ878595; 
EF563173 
Greece 
AM285220; AM285242; AM285267; AM937019; AM937024 Greenland 
DQ877830; DQ877832 Ireland 
AY375051; AY362443; DQ348057; DQ348033; DQ345139; 
DQ345123; DQ345246; DQ345123; DQ345262; DQ345233; 
DQ345221; AF251947; AF252026; AF376547; AF493371; 
AF517266; AF517471; AY672455; AY352444; AY855419; 
AY855724; AY994341; AY995503; DQ345170; DQ345265; 
DQ369253; DQ672623; DQ878603; EF526205; EU019810; 
EU496146; FJ228037; FJ228081; FJ228038; FJ209055; FJ209061; 
FJ228131; FJ228123; FJ228127;  HM990501.1; HM990500.1; 
HM990485.1; HM990469.1; HM990443.1; HM990432.1;  
FJ228038.1 
FJ228036.1; GU969575.1; GU969555.1; GU969546.1; GU969500.1 
 
 
 
Italy 
DQ877749; EF563190 Luxembourg 
AY423387; AY423383; AY877314; DQ877839; U34604; 
GQ399672; DQ877848 
Netherlands 
DQ663718; DQ663758; DQ666409; DQ666416; DQ877854; 
DQ877866; DQ877875; EF563195 
Portugal 
JN982165; JN982159, JN982157; JN982198; JN982190; JN982162; 
JN982158 
Romania 
JX290245; JX290243; JX290239; JX290244; JX290242;  KX517406; 
KX517405; KX517394; KX517388; KX46528; KX465287; 
KX465276; 
KX465274 
 
Russia 
AJ971111; AJ971144 Slovenia 
AF256207; AJ006287; AY188561; AY315950; AY316009; 
AY541992; AY542131; AY833593; DQ103904; DQ878901; 
DQ878956; EF397445; EF583196; EF583217; EF583285; 
EU255372; EU255417; EU255511; EU252228; EU786674; 
JQ828989; JX140659; JX140674 
 
 
 
 
Spain 
AF368317; AF378391; AF394468; AY165277; AY165231; 
DQ877891 
Sweden 
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. 
 
 
  
AF077679; AF316851; DQ877898; EF449825; EF449848; 
GU344240; GU344255 
 
 
Switzerland 
EF517434; DQ013272.1; DQ013269 South Africa 
AF181126; AF494109; AY362127; DQ879066; EU236465; 
EU817055 
United 
Kingdom 
HQ115072; HQ115066, DQ055312; DQ055292; DQ055331; 
DQ055325; DQ055321 
Ukraine 
JX161447; JX161313; JX161215; JX161335; JX161079; JX161023; 
JX160755; JX160671; JX160659; JX161424;  JX161084; GU331235; 
GU331229 
USA 
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APPENDIX 2. Table AII. Accession numbers and country of origins of 60 pol 
gene and 60 env gene background control sequences obtained by NCBI 
database BLAST. 
 
POL GENE ENV GENE 
ACCESSION 
NUMBER 
COUNTRY OF 
ORIGIN 
ACCESSION 
NUMBER 
COUNTRY OF 
ORIGIN 
HQ655137.1 Montenegro HQ595795.1 United Kingdom 
KT168102.1 USA DQ410258.1 USA 
KT168100.1 USA AY614970.1 USA 
KT168110.1 USA KX129198.1 USA 
KT168108.1 USA FJ222419.1 USA 
AY835771.1 USA AY614940.1 USA 
KT168168.1 USA JQ609969.1 USA 
KT168111.1 USA JQ609965.1 USA 
KT168097.1 USA FJ222418.1 USA 
AY835770.1 USA AY614939.1 USA 
AY835755.1 USA AY247218.1 USA 
KT168124.1 USA GQ118605.1 USA 
KT168109.1 USA KX129207.1 USA 
KT167927.1 USA EU184348.1 USA 
KT168104.1 USA AY614905.1 USA 
KT168124.1 USA KX129197.1 USA 
JQ650584.1 Netherlands JQ609968.1 USA 
JX299701.1 Germany HQ231110.1 Netherlands 
KX465993.1 Germany HQ231101.1 Netherlands 
KX465994.1 Germany HQ231099.1 Netherlands 
KJ771209.1 Germany EU744029.1 Netherlands 
KJ770207.1 Germany EU744020.1 Netherlands 
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JX299701.1 Germany HQ644937.1 Netherlands 
JX300212.1 Austria EU744034.1 Netherlands 
KP013647.1 Slovenia EU744028.1 Netherlands 
GU807516.1 Venezuela EU744023.1 Netherlands 
JQ698863.1 Sweden HQ644910.1 Netherlands 
AF251949.1 Italy GU455498.1 Netherlands 
KT167848.1 Canada EU744043.1 Netherlands 
GU344259.1 Switzerland EU744019.1 Netherlands 
AF447821.1 Thailand AY669729.1 Thailand 
KF745481.1 Thailand U08801.1 Thailand 
AF447830.1 Thailand DQ354116.1 Thailand 
KF745264.1 Thailand DQ354120.1 Thailand 
KF745563.1 Thailand DQ354114.1 Thailand 
JN248343 Thailand JN248351.1 Thailand 
AF362994.1 Thailand JN248350.1 Thailand 
KF745691.1 Thailand KC749047.1 Thailand 
DQ354119.1 Thailand HM215396.1 Thailand 
AY713408.1 Thailand AY945710.1 Thailand 
KF745662.1 Thailand KJ953227.1 Thailand 
KF745673.1 Thailand KJ953201.1 Thailand 
AF191194.1 Thailand DQ354119.1 Thailand 
AF345971.1 Thailand U08802.1 Thailand 
AF191205.1 Thailand KJ952538.1 Thailand 
KF745619.1 Thailand KC749034.1 Thailand 
DQ354118.1 Thailand DQ354118.1 Thailand 
KF745670.1 Thailand AF209201.1 Thailand 
KF745355.1 Thailand JQ715413.1 Thailand 
KP109514.1_ Thailand JX446822.1 Thailand 
JX448097.1 Thailand JX446817.1 Thailand 
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HQ898636.1 Thailand JN248325.1 Thailand 
DQ354116.1 Thailand KC749040.1 Thailand 
DQ354112.1 Thailand KC749036.1 Thailand 
KF745513.1 Thailand KC749033.1 Thailand 
KF745225.1 Thailand KC749054.1 Thailand 
KF745501.1 Thailand KC749048.1 Thailand 
KF745379.1 Thailand AF209204.1 Thailand 
AF240383.1 Thailand AF209203.1 Thailand 
AF447821.1 Thailand KJ953200 Thailand 
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